tick,link,time
ABBV,https://www.nasdaq.com/press-release/collaboration-between-abbvie-biogen-and-pfizer-creates-worlds-largest-browsable-0,"JUL 8, 2021 4:06PM EDT"
ABC,https://www.nasdaq.com/press-release/amerisourcebergen-announces-date-and-time-for-third-quarter-fiscal-2021-earnings,"JUN 24, 2021 4:15PM EDT"
ABCL,https://www.nasdaq.com/press-release/abcellera-appoints-neil-berkley-as-chief-business-officer-2021-07-13,"JUL 13, 2021 9:00AM EDT"
ABCM,https://www.nasdaq.com/press-release/abcam-opens-new-us-facility-in-boston-ma-2021-07-13,"JUL 13, 2021 7:00AM EDT"
ABEO,https://www.nasdaq.com/press-release/abeona-therapeutics-announces-updated-eb-101-phase-1-2a-clinical-results-in-recessive,"JUL 7, 2021 7:30AM EDT"
ABIO,https://www.nasdaq.com/press-release/arca-biopharma-provides-update-on-aspen-covid-19-phase-2b-clinical-trial-evaluating,"JUL 13, 2021 8:00AM EDT"
ABMD,https://www.nasdaq.com/press-release/fda-grants-highest-level-of-approval-to-the-next-generation-of-impella-rp-to-treat,"JUN 29, 2021 8:03AM EDT"
ABT,https://www.nasdaq.com/press-release/abbotts-xience-stent-receives-fda-approval-for-shortest-blood-thinner-course-for-high,"JUN 30, 2021 9:00AM EDT"
ABUS,https://www.nasdaq.com/press-release/arbutus-receives-authorization-to-proceed-with-an-investigational-new-drug,"JUL 7, 2021 7:00AM EDT"
ACAD,https://www.nasdaq.com/press-release/acadia-pharmaceuticals-to-present-new-scientific-data-on-pimavanserin-in-0,"JUL 14, 2021 9:00AM EDT"
ACER,https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0,"JUL 8, 2021 11:20AM EDT"
ACET,https://www.nasdaq.com/press-release/adicet-bio-added-to-the-russell-2000r-index-2021-06-28,"JUN 28, 2021 7:00AM EDT"
ACHC,https://www.nasdaq.com/press-release/acadia-healthcare-announces-date-for-second-quarter-2021-earnings-release-2021-07-12,"JUL 12, 2021 11:00AM EDT"
ACHV,https://www.nasdaq.com/press-release/achieve-announces-completion-of-target-enrollment-of-750-subjects-in-phase-3-orca-2,"JUN 29, 2021 5:30AM EDT"
ACIU,https://www.nasdaq.com/press-release/ac-immune-holds-its-annual-general-meeting-of-shareholders-2021-06-25,"JUN 25, 2021 8:38AM EDT"
ACOR,https://www.nasdaq.com/press-release/acorda-therapeutics-announces-repayment-of-convertible-senior-notes-2021-06-16,"JUN 16, 2021 7:00AM EDT"
ACRS,https://www.nasdaq.com/press-release/aclaris-therapeutics-to-participate-in-the-william-blair-biotech-focus-conference,"JUL 8, 2021 7:00AM EDT"
ACRX,https://www.nasdaq.com/press-release/acelrx-enters-into-licensing-agreement-for-dzuveor-in-europe-and-in-licensing,"JUL 14, 2021 8:30AM EDT"
ACST,https://www.nasdaq.com/press-release/acasti-pharma-provides-fiscal-2021-year-end-business-update-2021-06-22,"JUN 22, 2021 7:00AM EDT"
ADAP,https://www.nasdaq.com/press-release/two-complete-responses-and-response-rate-of-41-for-people-with-synovial-sarcoma,"MAY 19, 2021 5:00PM EDT"
ADCT,https://www.nasdaq.com/press-release/adc-therapeutics-announces-encouraging-interim-results-from-pivotal-phase-2-clinical,"JUN 22, 2021 9:55AM EDT"
ADIL,https://www.nasdaq.com/press-release/adial-announces-%245000000-above-market-private-placement-at-%243.00-per-share-2021-07-07,"JUL 7, 2021 10:11AM EDT"
ADILW,,"JUN 14, 2021 7:00AM EDT"
ADMA,https://www.nasdaq.com/press-release/adma-biologics-to-participate-in-the-raymond-james-human-health-innovation-virtual,"JUL 13, 2021 8:00AM EDT"
ADMP,https://www.nasdaq.com/press-release/adamis-urges-stockholders-to-vote-to-reelect-the-companys-board-of-directors-at,"JUL 9, 2021 4:05PM EDT"
ADMS,https://www.nasdaq.com/press-release/adamas-announces-new-employment-inducement-grant-2021-07-09,"JUL 12, 2021 4:05PM EDT"
ADPT,https://www.nasdaq.com/press-release/adaptive-biotechnologies-to-report-second-quarter-financial-results-on-august-4-2021,"JUL 12, 2021 8:00AM EDT"
ADTX,https://www.nasdaq.com/press-release/aditxt-launches-high-sensitivity-neutralizing-antibody-test-to-detect-individual,"JUL 13, 2021 8:00AM EDT"
ADUS,https://www.nasdaq.com/press-release/addus-homecare-signs-definitive-agreement-to-acquire-armada-skilled-home-health-and,"JUL 1, 2021 8:00AM EDT"
ADVM,https://www.nasdaq.com/press-release/adverum-announces-appointment-of-jon-williams-ph.d.-as-vice-president-clinical,"JUL 8, 2021 11:20AM EDT"
ADXN,https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0,"JUL 6, 2021 6:00AM EDT"
ADXS,https://www.nasdaq.com/press-release/advaxis-and-biosight-announce-entry-into-definitive-merger-agreement-2021-07-06,"JUN 24, 2021 4:15PM EDT"
AEMD,https://www.nasdaq.com/press-release/aethlon-medical-announces-fiscal-year-end-financial-results-and-provides-corporate-0,"JUN 21, 2021 7:00AM EDT"
AERI,https://www.nasdaq.com/press-release/aerie-pharmaceuticals-announces-appointment-of-frank-estrada-ed.d.-as-director,"JUN 7, 2021 8:05AM EDT"
AEZS,https://www.nasdaq.com/press-release/aeterna-zentaris-engages-dr.-michael-levy-to-support-development-of-autoimmune-and,"JUL 12, 2021 4:30PM EDT"
AFIB,https://www.nasdaq.com/press-release/acutus-medical-inc.-announces-proposed-public-offering-of-common-stock-2021-07-12,"JUL 1, 2021 6:30AM EDT"
AFMD,https://www.nasdaq.com/press-release/affimed-reports-first-quarter-2021-financial-results-and-highlights-operational,"MAY 17, 2021 4:05PM EDT"
AGE,https://www.nasdaq.com/press-release/agex-therapeutics-reports-first-quarter-2021-financial-results-and-provides-business,"JUL 7, 2021 4:05PM EDT"
AGEN,https://www.nasdaq.com/press-release/agenus-to-participate-in-resistance-focused-oncology-panel-at-the-william-blair,"JUN 28, 2021 7:00AM EDT"
AGIO,https://www.nasdaq.com/press-release/agios-submits-marketing-authorisation-application-to-european-medicines-agency-for,"JUL 8, 2021 8:30AM EDT"
AGLE,https://www.nasdaq.com/press-release/aeglea-biotherapeutics-appoints-jonathan-d.-alspaugh-as-chief-financial-officer-2021,"JUL 8, 2021 11:20AM EDT"
AGRX,https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0,"JUL 8, 2021 7:00AM EDT"
AGTC,https://www.nasdaq.com/press-release/agtc-to-host-virtual-rd-day-on-july-22-2021-2021-07-08,"JUL 13, 2021 8:15AM EDT"
AHCO,https://www.nasdaq.com/press-release/adapthealth-corp.-schedules-second-quarter-2021-financial-results-and-conference-call,"JUN 24, 2021 6:00AM EDT"
AHPI,,"JUL 13, 2021 10:00AM EDT"
AIH,https://www.nasdaq.com/press-release/aesthetic-medical-international-holdings-group-limited-reports-first-quarter-2021,"JUL 9, 2021 7:25AM EDT"
AIKI,https://www.nasdaq.com/press-release/aikido-pharma-to-attend-the-alzheimers-association-international-conference-2021-07,"JUL 1, 2021 4:05PM EDT"
AIM,https://www.nasdaq.com/press-release/aim-immunotech-announces-phase-2a-human-challenge-trial-to-test-its-drug-ampligen-as,"JUL 14, 2021 8:00AM EDT"
AKBA,https://www.nasdaq.com/press-release/akebia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-5,"JUL 7, 2021 9:15AM EDT"
AKER,,"JUN 25, 2021 7:17AM EDT"
AKRO,https://www.nasdaq.com/press-release/akero-therapeutics-appoints-judy-chou-ph.d.-to-its-board-of-directors-2021-07-14,"MAY 13, 2021 7:00AM EDT"
AKTX,https://www.nasdaq.com/press-release/akari-therapeutics-announces-private-placement-2021-07-07,"JUL 8, 2021 8:30AM EDT"
AKU,https://www.nasdaq.com/press-release/alliance-healthcare-services-announces-acquisition-by-and-integration-with-akumin,"JUN 28, 2021 12:00PM EDT"
AKUS,https://www.nasdaq.com/press-release/akouos-reports-first-quarter-2021-financial-results-and-provides-business-updates,"JUL 1, 2021 8:00AM EDT"
ALBO,https://www.nasdaq.com/press-release/albireo-to-present-at-the-william-blair-biotech-focus-conference-2021-2021-07-08,"JUL 2, 2021 7:38AM EDT"
ALC,https://www.nasdaq.com/press-release/alcon-announces-executive-committee-changes-2021-06-28,"JUL 1, 2021 8:30AM EDT"
ALDX,https://www.nasdaq.com/press-release/aldeyra-therapeutics-joins-the-russell-2000r-and-russell-3000r-indexes-2021-07-01,"JUN 30, 2021 10:08PM EDT"
ALEC,https://www.nasdaq.com/press-release/alector-and-gsk-announce-global-collaboration-in-immuno-neurology-for-two-clinical,"MAY 27, 2021 7:15PM EDT"
ALGN,https://www.nasdaq.com/press-release/align-technology-to-announce-second-quarter-2021-results-on-july-28-2021-2021-07-01,"JUL 13, 2021 12:16PM EDT"
ALGS,https://www.nasdaq.com/press-release/aligos-therapeutics-announces-pricing-of-%2483.6-million-public-offering-of-common,"JUN 7, 2021 8:00AM EDT"
ALIM,https://www.nasdaq.com/press-release/35-of-the-best-ideas-companies-to-present-at-the-summer-solstice-best-ideas-from-the,"JUL 12, 2021 8:30AM EDT"
ALKS,https://www.nasdaq.com/press-release/alkermes-presented-new-data-analysis-on-healthcare-resource-use-among-veterans-with-0,"JUL 13, 2021 11:43PM EDT"
ALLK,https://www.nasdaq.com/press-release/allakos-completes-patient-enrollment-in-phase-3-eosinophilic-gastritis-and-or,"JUN 30, 2021 7:00AM EDT"
ALLO,https://www.nasdaq.com/press-release/allogene-therapeutics-announces-participation-in-two-upcoming-virtual-investor-0,"JUN 30, 2021 8:00AM EDT"
ALNA,https://www.nasdaq.com/press-release/allena-pharmaceuticals-announces-%2428-million-registered-direct-offering-priced-at-the,"JUL 8, 2021 8:15AM EDT"
ALNY,https://www.nasdaq.com/press-release/alnylam-initiates-kardia-1-phase-2-study-of-zilebesiran-aln-agt-in-patients-with-mild,"JUN 29, 2021 4:01PM EDT"
ALPN,https://www.nasdaq.com/press-release/alpine-immune-sciences-to-collaborate-with-merck-on-immuno-oncology-study-to-evaluate,"MAY 6, 2021 7:00AM EDT"
ALRN,https://www.nasdaq.com/press-release/aileron-therapeutics-to-participate-in-fireside-chat-at-the-william-blair-biotech,"JUL 14, 2021 8:51AM EDT"
ALT,https://www.nasdaq.com/press-release/altimmune-announces-update-on-adcovidtm-phase-1-clinical-trial-2021-06-29,"JUL 3, 2021 7:15AM EDT"
ALVR,https://www.nasdaq.com/press-release/allovir-reports-first-quarter-2021-financial-results-2021-05-06,"JUL 13, 2021 8:00AM EDT"
ALXN,https://www.nasdaq.com/press-release/accelerating-results-for-patients-2021-07-14,"JUL 14, 2021 8:00AM EDT"
ALXO,https://www.nasdaq.com/press-release/alx-oncology-announces-new-data-from-aspen-01-the-phase-1b-study-of-alx148-showing-0,"JUL 14, 2021 9:15AM EDT"
AMED,https://www.nasdaq.com/press-release/amedisys-to-open-westchester-county-home-health-care-center-2021-07-13,"JUN 15, 2021 4:05PM EDT"
AMGN,https://www.nasdaq.com/press-release/amgen-and-the-international-federation-of-psoriasis-associations-launch-uplift,"JUN 2, 2021 4:30PM EDT"
AMPE,https://www.nasdaq.com/press-release/ampio-pharmaceuticals-inc.-to-report-fiscal-2021-second-quarter-financial-results-and,"JUN 17, 2021 8:00AM EDT"
AMPH,https://www.nasdaq.com/press-release/amphastar-pharmaceuticals-to-present-at-the-raymond-james-human-health-innovation,"MAY 13, 2021 8:00AM EDT"
AMRN,https://www.nasdaq.com/press-release/further-insights-into-mechanism-of-action-of-icosapent-ethyl-and-its-unique-form-of,"JUL 9, 2021 8:00AM EDT"
AMRX,https://www.nasdaq.com/press-release/amneal-announces-u.s.-fda-filing-acceptance-of-biologics-license-application-bla-for,"JUL 12, 2021 7:00AM EDT"
AMS,https://www.nasdaq.com/press-release/american-shared-hospital-services-reports-first-quarter-2021-financial-results-2021,"MAY 27, 2021 4:15PM EDT"
AMTI,https://www.nasdaq.com/press-release/applied-molecular-transport-presents-additional-positive-data-from-oral-amt-101-phase,"JUN 29, 2021 4:05PM EDT"
AMYT,https://www.nasdaq.com/press-release/amryt-to-report-q2-2021-results-and-host-conference-call-webcast-on-august-6-2021-07,"JUL 13, 2021 7:00AM EDT"
ANAB,https://www.nasdaq.com/press-release/anaptysbio-to-present-at-the-2021-jefferies-virtual-healthcare-conference-2021-05-27,"JUL 1, 2021 9:00AM EDT"
ANCN,,"JUL 6, 2021 6:50AM EDT"
ANGN,https://www.nasdaq.com/press-release/angion-announces-results-from-the-phase-2-ali-201-study-in-patients-with-covid-19,"MAY 26, 2021 8:30AM EDT"
ANGO,https://www.nasdaq.com/press-release/angiodynamics-reports-fiscal-2021-fourth-quarter-and-full-year-financial-results-2021,"JUN 16, 2021 7:00AM EDT"
ANIK,https://www.nasdaq.com/press-release/first-anika-wristmotionr-total-wrist-arthroplasty-surgery-performed-2021-07-01,"JUN 18, 2021 6:30AM EDT"
ANIP,https://www.nasdaq.com/press-release/ani-pharmaceuticals-announces-refiling-of-cortrophin-snda-with-fda-2021-07-06,"JUL 14, 2021 9:27AM EDT"
ANIX,https://www.nasdaq.com/press-release/anixa-biosciences-announces-support-from-the-national-cancer-institute-for-ovarian,"JUN 10, 2021 8:30AM EDT"
ANNX,https://www.nasdaq.com/press-release/annexon-to-present-at-the-raymond-james-human-health-innovation-conference-2021-06-16,"JUN 14, 2021 7:30AM EDT"
ANPC,https://www.nasdaq.com/press-release/anpac-bios-first-disease-treatment-patent-granted-and-its-cancer-treatment-project,"JUL 7, 2021 10:06PM EDT"
ANTM,https://www.nasdaq.com/press-release/hispanic-latino-communities-lead-telehealth-visits-for-mental-health-services-during,"JUN 28, 2021 7:00AM EDT"
ANVS,https://www.nasdaq.com/press-release/annovis-bio-to-present-at-2021-bio-digital-2021-06-10,"JUL 12, 2021 8:00AM EDT"
APEN,https://www.nasdaq.com/press-release/merit-study-investigators-announce-successful-achievement-of-the-studys-primary,"JUN 16, 2021 6:58PM EDT"
APLS,https://www.nasdaq.com/press-release/apellis-announces-agreements-to-exchange-approximately-%24198.6-million-in-principal,"JUN 16, 2021 8:00AM EDT"
APLT,https://www.nasdaq.com/press-release/applied-therapeutics-added-to-russell-microcapr-index-2021-06-28,"MAY 24, 2021 9:00AM EDT"
APM,https://www.nasdaq.com/press-release/aptorum-group-announces-further-positive-interim-results-of-the-phase-1-clinical,"JUN 11, 2021 7:55AM EDT"
APOP,https://www.nasdaq.com/press-release/cellect-biotechnology-files-registration-statement-in-connection-with-proposed,"JUL 12, 2021 7:57AM EDT"
APOPW,,"JUN 30, 2021 8:05AM EDT"
APRE,https://www.nasdaq.com/press-release/aprea-therapeutics-announces-phase-1-2-trial-of-eprenetapopt-venetoclax-azacitidine,"JUL 12, 2021 4:05PM EDT"
APT,https://www.nasdaq.com/press-release/alpha-pro-tech-ltd.-announces-2021-annual-meeting-of-shareholders-to-be-held-in,"JUN 24, 2021 8:00AM EDT"
APTO,https://www.nasdaq.com/press-release/aptose-presents-highlights-from-eha-during-corporate-update-event-2021-06-11,"JUL 7, 2021 7:00AM EDT"
APTX,https://www.nasdaq.com/press-release/aptinyx-to-participate-in-william-blair-biotech-focus-conference-2021-2021-07-12,"JUN 24, 2021 7:30AM EDT"
APVO,https://www.nasdaq.com/press-release/aptevo-therapeutics-scientists-to-present-at-virtual-cell-engager-summit-2021-06-30,"JUL 6, 2021 9:00AM EDT"
APYX,https://www.nasdaq.com/press-release/apyx-medical-corporation-to-release-second-quarter-of-fiscal-year-2021-financial,"JUL 12, 2021 4:05PM EDT"
AQST,https://www.nasdaq.com/press-release/aquestive-therapeutics-resubmits-new-drug-application-for-libervanttm-diazepam-buccal,"JUN 7, 2021 8:00AM EDT"
ARAV,https://www.nasdaq.com/press-release/aravive-to-participate-in-fireside-chat-at-2021-william-blair-biotech-focus,"JUL 14, 2021 1:00AM EDT"
ARAY,https://www.nasdaq.com/press-release/beloved-family-pets-lung-cancer-is-treated-with-targeted-radiotherapy-using-the,"JUL 7, 2021 7:30AM EDT"
ARCT,https://www.nasdaq.com/press-release/arcturus-therapeutics-to-present-at-upcoming-investor-and-scientific-conferences-2,"JUN 18, 2021 4:05PM EDT"
ARDS,https://www.nasdaq.com/press-release/aridis-pharmaceuticals-covid-mab-ar-712-neutralizes-sars-cov-2-delta-variant-2021-07,"JUN 4, 2021 9:15AM EDT"
ARDX,https://www.nasdaq.com/press-release/ardelyx-announces-presentations-at-era-edta-virtual-congress-2021-2021-06-07,"JUL 12, 2021 8:30AM EDT"
ARGX,https://www.nasdaq.com/press-release/argenx-to-host-virtual-rd-day-on-july-20-2021-2021-07-14,"JUN 7, 2021 5:19PM EDT"
ARMP,https://www.nasdaq.com/press-release/armata-pharmaceuticals-to-present-at-the-ladenburg-thalmann-2021-healthcare,"JUL 14, 2021 7:30AM EDT"
ARNA,https://www.nasdaq.com/press-release/arena-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14,"JUL 13, 2021 7:00AM EDT"
ARPO,https://www.nasdaq.com/press-release/aerpio-provides-second-update-on-aadi-bioscience-presentation-at-the-asco-2021,"JUL 2, 2021 5:00PM EDT"
ARQT,,"JUL 6, 2021 8:00AM EDT"
ARTL,https://www.nasdaq.com/press-release/artelo-biosciences-reports-third-quarter-fiscal-2021-financial-results-and-provides,"JUN 4, 2021 9:27AM EDT"
ARTLW,,"JUL 12, 2021 9:00AM EDT"
ARVN,https://www.nasdaq.com/press-release/arvinas-participates-in-groundbreaking-ceremony-for-new-space-within-downtown,"JUL 6, 2021 7:00AM EDT"
ARWR,https://www.nasdaq.com/press-release/arrowhead-pharmaceuticals-to-webcast-fiscal-2021-third-quarter-results-2021-07-14,"JUL 13, 2021 10:30AM EDT"
ASLN,https://www.nasdaq.com/press-release/aslan-pharmaceuticals-announces-loan-facility-providing-up-to-%2445-million-from-k2,"JUL 12, 2021 9:51AM EDT"
ASMB,https://www.nasdaq.com/press-release/assembly-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8,"JUN 28, 2021 8:30AM EDT"
ASND,https://www.nasdaq.com/press-release/ascendis-pharma-a-s-announces-target-enrollment-achieved-in-the-phase-3-pathway-trial,"JUL 6, 2021 7:00AM EDT"
ASRT,https://www.nasdaq.com/press-release/assertio-holdings-inc.-regains-compliance-with-nasdaq-minimum-bid-price-requirement,"JUL 7, 2021 9:30AM EDT"
ATEC,https://www.nasdaq.com/press-release/atec-announces-select-preliminary-second-quarter-2021-financial-results-2021-07-12,"JUL 2, 2021 4:01PM EDT"
ATHA,https://www.nasdaq.com/press-release/athira-pharma-announces-initiation-of-open-label-extension-study-for-lift-ad-and-act,"JUL 7, 2021 8:00AM EDT"
ATHE,,"MAY 21, 2021 2:51PM EDT"
ATHX,https://www.nasdaq.com/press-release/athersys-to-host-second-quarter-financial-results-call-2021-07-13,"JUL 7, 2021 8:30AM EDT"
ATNF,https://www.nasdaq.com/press-release/180-life-sciences-regains-nasdaq-compliance-for-listing-rules-5605b1-and-5605c2-2021,"JUN 14, 2021 7:00AM EDT"
ATNFW,,"JUN 30, 2021 7:05AM EDT"
ATNM,https://www.nasdaq.com/press-release/actinium-pharmaceuticals-announces-inclusion-in-russell-microcapr-index-2021-06-28,"JUL 8, 2021 7:00AM EDT"
ATNX,https://www.nasdaq.com/press-release/athenex-provides-update-from-fda-type-a-meeting-regarding-oral-paclitaxel-plus,"JUL 7, 2021 8:00AM EDT"
ATOS,https://www.nasdaq.com/press-release/atossa-therapeutics-receives-regulatory-approval-to-open-clinical-study-of-at-h201-in,"JUL 8, 2021 4:05PM EDT"
ATRA,https://www.nasdaq.com/press-release/atara-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6,"JUL 6, 2021 8:30AM EDT"
ATRC,https://www.nasdaq.com/press-release/atricure-to-announce-second-quarter-2021-financial-results-2021-07-07,"JUL 12, 2021 7:00AM EDT"
ATRI,https://www.nasdaq.com/press-release/atrion-corporation-declares-quarterly-cash-dividend-2021-05-21,"JUL 12, 2021 7:15AM EDT"
ATRS,https://www.nasdaq.com/press-release/antares-pharma-to-present-at-the-ladenburg-thalmann-annual-healthcare-conference-2021,"JUL 8, 2021 7:00AM EDT"
ATXI,https://www.nasdaq.com/press-release/avenue-therapeutics-receives-complete-response-letter-from-the-fda-for-iv-tramadol-0,"JUN 28, 2021 7:00AM EDT"
AUPH,https://www.nasdaq.com/press-release/aurinia-awards-%24250000-in-grants-to-support-patient-navigation-programs-2021-06-30,"JUL 8, 2021 8:00AM EDT"
AUTL,https://www.nasdaq.com/press-release/autolus-therapeutics-to-report-second-quarter-2021-financial-results-on-august-5-2021,"JUL 14, 2021 7:00AM EDT"
AVDL,https://www.nasdaq.com/press-release/avadel-pharmaceuticals-to-present-at-the-ladenburg-thalmann-annual-healthcare,"JUN 30, 2021 7:28AM EDT"
AVEO,https://www.nasdaq.com/press-release/aveo-oncology-to-host-key-opinion-leader-webinar-on-fotivdar-tivozanib-for-relapsed,"JUL 14, 2021 8:00AM EDT"
AVGR,https://www.nasdaq.com/press-release/avinger-announces-510k-filing-for-new-pantheris-in-stent-restenosis-indication-2021,"JUN 15, 2021 7:00AM EDT"
AVIR,https://www.nasdaq.com/press-release/atea-pharmaceuticals-to-present-at-william-blair-biotech-focus-conference-2021-07-12,"JUL 6, 2021 9:00AM EDT"
AVNS,https://www.nasdaq.com/press-release/avanos-medical-inc.-appoints-moji-james-as-senior-vice-president-general-counsel-2021,"JUN 28, 2021 8:50AM EDT"
AVRO,https://www.nasdaq.com/press-release/avrobio-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-08,"JUL 13, 2021 2:00AM EDT"
AVXL,https://www.nasdaq.com/press-release/anavex-life-sciences-announces-anavexr2-73-blarcamesine-improved-both-primary,"JUN 8, 2021 7:00AM EDT"
AWH,https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announces-coverage-for-ova1r-in-the-aim-specialty-health,"JUN 7, 2021 8:00AM EDT"
AXGN,https://www.nasdaq.com/press-release/axogen-inc.-to-report-second-quarter-financial-results-and-host-conference-call-on,"JUL 12, 2021 6:30PM EDT"
AXLA,https://www.nasdaq.com/press-release/axcella-announces-initiation-of-emmpowersm-phase-2-clinical-trial-of-axa1665-2021-06,"JUL 6, 2021 8:00AM EDT"
AXNX,https://www.nasdaq.com/press-release/biolife-solutions-announces-changes-to-board-of-directors-2021-07-14,"JUL 12, 2021 4:30PM EDT"
AXSM,https://www.nasdaq.com/press-release/axsome-therapeutics-announces-planned-nda-submission-for-axs-14-for-the-management-of,"MAY 12, 2021 6:26PM EDT"
AYLA,https://www.nasdaq.com/press-release/ayala-pharmaceuticals-to-present-at-ladenburg-thalmann-healthcare-conference-2021-07,"JUN 23, 2021 8:00AM EDT"
AYTU,https://www.nasdaq.com/press-release/aytu-biopharma-announces-peer-reviewed-publication-of-clinical-results-from,"MAY 14, 2021 8:30AM EDT"
AZN,https://www.nasdaq.com/press-release/hutchmed-announces-first-commercial-sale-of-orpathysr-in-china-triggering-a-us%2425,"JUN 15, 2021 9:21AM EDT"
AZRX,https://www.nasdaq.com/press-release/azurrx-biopharma-ceo-james-sapirstein-to-present-at-2021-bio-digital-2021-06-08,"JUL 10, 2021 10:00AM EDT"
AZYO,https://www.nasdaq.com/press-release/aziyo-biologics-comments-on-june-2nd-voluntary-recall-of-one-lot-of-its-fibercel,"JUL 13, 2021 6:59AM EDT"
BASI,,"MAY 6, 2021 8:00AM EDT"
BAX,https://www.nasdaq.com/press-release/baxter-declares-quarterly-dividend-2021-07-12,"JUN 17, 2021 4:01PM EDT"
BBI,https://www.nasdaq.com/press-release/brickell-biotech-to-participate-at-william-blairs-biotech-focus-conference-2021-2021,"MAY 19, 2021 5:00PM EDT"
BBIO,https://www.nasdaq.com/press-release/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07,"JUL 12, 2021 6:50AM EDT"
BCAB,https://www.nasdaq.com/press-release/bioatla-announces-first-quarter-2021-financial-results-and-provides-business-update,"DEC 2, 2020 7:00AM EST"
BCDA,https://www.nasdaq.com/press-release/biocardia-announces-fourth-positive-dsmb-review-and-recommendation-to-continue-phase,"JUL 8, 2021 6:30AM EDT"
BCDAW,,"FEB 2, 2021 6:50PM EST"
BCEL,https://www.nasdaq.com/press-release/atreca-to-present-at-upcoming-virtual-investor-conferences-2021-05-14,"JUL 6, 2021 5:59PM EDT"
BCLI,https://www.nasdaq.com/press-release/brainstorm-announces-expansion-of-nurownr-ip-portfolio-with-grant-and-allowance-of,"JUL 9, 2021 12:00AM EDT"
BCRX,https://www.nasdaq.com/press-release/biocryst-reports-96-week-data-from-apex-2-showing-orladeyorberotralstat-reduced-hae,"JUL 12, 2021 6:59AM EDT"
BCYC,https://www.nasdaq.com/press-release/bicycle-therapeutics-enters-exclusive-license-and-collaboration-agreement-with-ionis,"JUL 7, 2021 7:00AM EDT"
BDSI,https://www.nasdaq.com/press-release/biodelivery-sciences-reports-first-quarter-2021-results-2021-05-06,"JUL 12, 2021 7:00PM EDT"
BDSX,https://www.nasdaq.com/press-release/biodesix-announces-presentation-on-novel-proteomic-techniques-in-partnership-with,"JUL 6, 2021 8:27AM EDT"
BDTX,https://www.nasdaq.com/press-release/black-diamond-therapeutics-presents-phase-1-pharmacokinetic-safety-and-preliminary,"JUN 3, 2021 9:00AM EDT"
BDX,https://www.nasdaq.com/press-release/bd-announces-two-future-directors-for-diabetes-care-spinoff-company-2021-07-12,"JUN 29, 2021 8:00AM EDT"
BDXB,https://www.nasdaq.com/press-release/bd-to-invest-%241.2-billion-in-pre-fillable-syringe-manufacturing-capacity-over-next-0,"JUL 9, 2021 7:00AM EDT"
BEAM,https://www.nasdaq.com/press-release/beam-therapeutics-to-participate-in-the-2021-william-blair-biotech-focus-conference,"JUN 28, 2021 7:30AM EDT"
BEAT,https://www.nasdaq.com/press-release/investors-bancorp-set-to-join-sp-smallcap-600-2021-02-02,"JUL 14, 2021 8:00AM EDT"
BFRA,https://www.nasdaq.com/press-release/biofrontera-inc.-seeks-ipo-in-the-usa-2021-07-06,"MAY 27, 2021 8:30AM EDT"
BGNE,https://www.nasdaq.com/press-release/beigene-announces-the-approval-in-china-of-kyprolisr-carfilzomib-for-injection-for,"MAY 26, 2021 7:00AM EDT"
BHC,https://www.nasdaq.com/press-release/bausch-lomb-launches-biotruer-hydration-boost-lubricant-eye-drops-and-biotruer,"MAY 25, 2021 7:00AM EDT"
BHVN,https://www.nasdaq.com/press-release/biohaven-announces-preliminary-2q2021-net-product-revenue-for-nurtec-odt-the-first,"JUL 9, 2021 7:30AM EDT"
BIIB,https://www.nasdaq.com/press-release/biogen-and-innocare-announce-license-and-collaboration-agreement-for-orelabrutinib-an,"JUL 8, 2021 11:20AM EDT"
BIOC,https://www.nasdaq.com/press-release/biocept-receives-south-korean-patent-for-primer-switch-platform-used-to-identify-rare,"JUL 14, 2021 8:30AM EDT"
BIOL,https://www.nasdaq.com/press-release/recent-studies-demonstrate-biolases-waterlase-laser-technology-is-beneficial-for,"JUN 29, 2021 7:06AM EDT"
BIVI,https://www.nasdaq.com/press-release/development-of-biovies-ne3107-asset-featured-by-the-american-diabetes-association,"MAY 25, 2021 12:19AM EDT"
BKD,https://www.nasdaq.com/press-release/brookdale-reports-june-2021-occupancy-2021-07-09,"APR 27, 2021 9:55PM EDT"
BLCM,https://www.nasdaq.com/press-release/bellicum-enters-license-agreement-with-unc-lineberger-and-mass-general-for-use-of,"JUN 18, 2021 5:00AM EDT"
BLFS,https://www.nasdaq.com/press-release/biolife-solutions-announces-changes-to-board-of-directors-2021-07-14,"JUN 4, 2021 9:00AM EDT"
BLPH,https://www.nasdaq.com/press-release/bellerophon-to-present-at-the-jefferies-virtual-healthcare-conference-2021-05-27,"JUL 7, 2021 4:01PM EDT"
BLRX,https://www.nasdaq.com/press-release/biolinerx-reports-first-quarter-2021-financial-results-and-provides-corporate-update,"JUN 22, 2021 7:00AM EDT"
BLU,https://www.nasdaq.com/press-release/bellus-health-to-participate-in-the-jefferies-virtual-healthcare-conference-2021-05,"JUL 13, 2021 2:30PM EDT"
BLUE,https://www.nasdaq.com/press-release/bluebird-bio-announces-positive-recommendation-by-prac-regarding-article-20-safety,"JUN 29, 2021 9:30AM EDT"
BMRA,https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0,"JUN 23, 2021 8:28AM EDT"
BMRN,https://www.nasdaq.com/press-release/biomarin-to-host-second-quarter-2021-financial-results-conference-call-and-webcast-on,"JUN 23, 2021 6:00AM EDT"
BMY,https://www.nasdaq.com/press-release/bristol-myers-squibb-receives-european-commission-approval-for-opdivo-nivolumab-1,"JUL 13, 2021 11:00AM EDT"
BNR,https://www.nasdaq.com/press-release/burning-rock-reports-first-quarter-2021-financial-results-2021-05-25,"JUL 1, 2021 7:00AM EDT"
BNTC,https://www.nasdaq.com/press-release/benitec-biopharma-increases-previously-announced-bought-deal-offering-of-common-stock,"JUL 14, 2021 7:30AM EDT"
BNTX,https://www.nasdaq.com/press-release/biontech-announces-first-patient-dosed-in-phase-2-clinical-trial-of-mrna-based-bnt111,"JUN 28, 2021 8:00AM EDT"
BOLT,https://www.nasdaq.com/press-release/bolt-biotherapeutics-presents-preliminary-results-from-phase-1-2-trial-of-lead-her2,"JUN 24, 2021 6:55AM EDT"
BPMC,https://www.nasdaq.com/press-release/blueprint-medicines-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-11,"JUN 7, 2021 8:00AM EDT"
BPTH,https://www.nasdaq.com/press-release/bio-path-granted-key-mechanism-of-action-u.s.-patent-for-bp1003-2021-06-22,"MAY 28, 2021 9:06AM EDT"
BSGM,https://www.nasdaq.com/press-release/biosig-latest-installation-broadens-clinical-footprint-for-its-signal-processing,"JUL 8, 2021 7:00AM EDT"
BSX,https://www.nasdaq.com/press-release/boston-scientific-announces-conference-call-discussing-second-quarter-2021-results,"JUN 17, 2021 9:00AM EDT"
BTAI,https://www.nasdaq.com/press-release/bioxcel-therapeutics-announces-pricing-of-public-offering-of-common-stock-2021-06-23,"JUN 11, 2021 7:30AM EDT"
BVXV,https://www.nasdaq.com/press-release/biondvax-announces-first-quarter-2021-financial-results-and-provides-business-update,"JUN 10, 2021 7:00AM EDT"
BWAY,https://www.nasdaq.com/press-release/mindpath-care-centers-hosts-open-house-in-charlotte-to-introduce-fda-cleared-deep,"JUL 7, 2021 8:00AM EDT"
BXRX,https://www.nasdaq.com/press-release/leading-independent-proxy-advisory-firm-glass-lewis-co.-recommends-baudax-bio-0,"JUN 21, 2021 8:00AM EDT"
BYSI,https://www.nasdaq.com/press-release/beyondspring-strengthens-board-with-the-addition-of-ex-immunomedics-and-constellation,"JUL 14, 2021 8:00AM EDT"
CABA,https://www.nasdaq.com/press-release/cabaletta-bio-appoints-biopharmaceutical-leader-scott-brun-m.d.-to-board-of-directors,"JUL 6, 2021 9:16AM EDT"
CAH,https://www.nasdaq.com/press-release/cardinal-health-to-webcast-discussion-of-fourth-quarter-and-year-end-results-for-1,"FEB 19, 2021 2:55PM EST"
CALA,https://www.nasdaq.com/press-release/final-data-from-calithera-biosciences-phase-2-cantata-study-in-renal-cell-carcinoma,"APR 20, 2021 4:30PM EDT"
CALT,https://www.nasdaq.com/press-release/calliditas-announces-submission-of-marketing-authorisation-application-for-nefecon-to,"JUN 11, 2021 6:11AM EDT"
CANF,https://www.nasdaq.com/press-release/can-fite-gears-up-to-initiate-pivotal-phase-iii-liver-cancer-study-2021-07-08,"JUL 6, 2021 8:30AM EDT"
CAPR,https://www.nasdaq.com/press-release/capricor-therapeutics-to-present-findings-from-hope-2-open-label-extension-study-at,"JUL 7, 2021 8:30AM EDT"
CARA,https://www.nasdaq.com/press-release/swk-holdings-subsidiary-enteris-biopharma-receives-%2410-million-milestone-payment-from,"JUL 1, 2021 8:05AM EDT"
CASI,https://www.nasdaq.com/press-release/casi-pharmaceuticals-announces-dosing-of-first-patient-of-cid-103-in-phase-1-clinical,"APR 15, 2021 4:05PM EDT"
CATB,https://www.nasdaq.com/press-release/catabasis-pharmaceuticals-to-present-at-ladenburg-thalmann-2021-healthcare-conference,"JUL 1, 2021 4:01PM EDT"
CBAY,https://www.nasdaq.com/press-release/cymabay-therapeutics-presents-positive-pbc-data-at-the-international-liver-congresstm,"JUL 12, 2021 8:00AM EDT"
CBIO,https://www.nasdaq.com/press-release/catalyst-biosciences-announces-key-leadership-changes-in-its-ongoing-transition-to-an,"JUL 8, 2021 4:15PM EDT"
CBLI,https://www.nasdaq.com/press-release/cleveland-biolabs-inc.-and-cytocom-inc.-announce-call-to-discuss-stockholder-meeting,"MAY 6, 2021 4:05PM EDT"
CBMG,https://www.nasdaq.com/press-release/cellular-biomedicine-group-inc.-announces-completion-of-merger-2021-02-19,"JUN 23, 2021 7:30AM EDT"
CBPO,https://www.nasdaq.com/press-release/china-biologic-announces-completion-of-going-private-transaction-2021-04-20,"JUL 1, 2021 9:50PM EDT"
CCCC,,"JUL 14, 2021 8:30AM EDT"
CCM,https://www.nasdaq.com/press-release/concord-medical-officially-opens-new-specialty-cancer-hospital-in-guangzhou-2021-06,"JUL 7, 2021 7:30AM EDT"
CCXI,https://www.nasdaq.com/press-release/chemocentryx-announces-filing-of-amendment-to-nda-submission-and-extension-of-the,"JUN 17, 2021 7:31AM EDT"
CDAK,https://www.nasdaq.com/press-release/codiak-biosciences-to-present-at-the-virtual-william-blair-biotech-focus-conference,"JUL 14, 2021 7:00AM EDT"
CDMO,https://www.nasdaq.com/press-release/avid-bioservices-announces-appointment-of-esther-m.-alegria-ph.d.-to-board-of,"JUL 2, 2021 12:17PM EDT"
CDMOP,https://www.nasdaq.com/press-release/avid-bioservices-announces-completion-of-redemption-of-series-e-convertible-preferred,"JUN 30, 2021 8:12AM EDT"
CDNA,https://www.nasdaq.com/press-release/caredx-transplant-patient-app-allocare-expands-access-to-the-majority-of-transplant,"JUN 28, 2021 4:12PM EDT"
CDTX,https://www.nasdaq.com/press-release/cidara-therapeutics-presents-new-analyses-from-multiple-rezafungin-studies-at-eccmid,"JUL 12, 2021 8:29PM EDT"
CELC,https://www.nasdaq.com/press-release/celcuity-to-participate-in-the-william-blair-biotech-focus-conference-2021-07-08,"JUL 13, 2021 9:00AM EDT"
CEMI,https://www.nasdaq.com/press-release/chembio-diagnostics-reports-first-quarter-2021-financial-results-2021-05-06,"JUL 14, 2021 8:30AM EDT"
CERC,https://www.nasdaq.com/press-release/cerecor-licenses-immune-checkpoint-program-from-sanford-burnham-prebys-further,"JUL 8, 2021 8:30AM EDT"
CERE,https://www.nasdaq.com/press-release/cerevel-therapeutics-announces-pricing-of-%24350-million-public-offering-of-common,"JUN 22, 2021 8:00AM EDT"
CEREW,,"JUL 13, 2021 8:30PM EDT"
CERS,https://www.nasdaq.com/press-release/cerus-corporation-and-the-swiss-red-cross-celebrate-10-years-of-routine-use-of,"JUL 12, 2021 4:30PM EDT"
CFMS,https://www.nasdaq.com/press-release/conformis-inc.-announces-settlement-of-wright-medical-patent-litigation-2021-07-07,"JUN 30, 2021 7:00AM EDT"
CFRX,https://www.nasdaq.com/press-release/contrafect-appoints-gary-woodnutt-ph.d.-as-senior-vice-president-of-translational,"JUL 9, 2021 9:00AM EDT"
CGEM,,"JUN 16, 2021 4:05PM EDT"
CGEN,https://www.nasdaq.com/press-release/compugen-to-release-second-quarter-2021-results-on-wednesday-july-28-2021-2021-07-14,"JUL 13, 2021 9:00AM EDT"
CGIX,,"JUN 15, 2021 7:05AM EDT"
CHE,https://www.nasdaq.com/press-release/chemed-to-report-second-quarter-2021-earnings-july-27-related-conference-call-to-be,"JUL 1, 2021 8:00AM EDT"
CHEK,https://www.nasdaq.com/press-release/check-cap-ltd.-announces-%2435-million-registered-direct-offering-2021-06-30,"JUL 1, 2021 9:09AM EDT"
CHEKZ,,"JUL 12, 2021 4:05PM EDT"
CHFS,,"MAY 26, 2021 5:50PM EDT"
CHMA,https://www.nasdaq.com/press-release/chiasma-announces-submission-of-marketing-authorization-application-for-mycapssar-to,"MAY 20, 2021 4:30PM EDT"
CHRS,https://www.nasdaq.com/press-release/coherus-biosciences-announces-new-employment-inducement-grants-2021-07-12,"JUN 4, 2021 2:10PM EDT"
CI,https://www.nasdaq.com/press-release/bonnie-evelyn-named-cigna-market-president-for-georgia-alabama-2021-07-13,"JUL 13, 2021 4:46PM EDT"
CJJD,https://www.nasdaq.com/press-release/china-jo-jo-drugstores-selected-as-one-of-the-first-batch-of-four-star-livelihood,"JUL 1, 2021 7:00AM EDT"
CKPT,https://www.nasdaq.com/press-release/checkpoint-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare,"JUL 1, 2021 4:05PM EDT"
CLBS,https://www.nasdaq.com/press-release/caladrius-biosciences-to-assess-its-clbs201-cd34-cell-therapy-in-diabetic-kidney,"JUL 12, 2021 7:30AM EDT"
CLDX,https://www.nasdaq.com/press-release/celldex-therapeutics-announces-pricing-of-upsized-%24250-million-public-offering-of,"JUL 1, 2021 10:45AM EDT"
CLLS,https://www.nasdaq.com/press-release/monthly-information-on-share-capital-and-company-voting-rights-2021-07-12,"JUN 25, 2021 6:30AM EDT"
CLNN,https://www.nasdaq.com/press-release/clene-to-host-expert-perspectives-webinar-on-cellular-energetic-failure-and-the-unmet,"JUN 28, 2021 4:16PM EDT"
CLNNW,,"JUN 28, 2021 8:00AM EDT"
CLOV,https://www.nasdaq.com/press-release/clover-health-expands-management-team-appointing-prabhdeep-singh-as-chief-growth,"JUN 18, 2021 10:30AM EDT"
CLOVW,,"JUN 29, 2021 7:00AM EDT"
CLPT,https://www.nasdaq.com/press-release/clearpoint-neuro-inc.-announces-installation-of-clearpointr-2.0-software-at,"JUN 16, 2021 4:01PM EDT"
CLRB,https://www.nasdaq.com/press-release/cellectar-announces-expansion-of-ongoing-collaboration-agreement-with-intocell-inc.,"JUL 14, 2021 9:15AM EDT"
CLRBZ,,"JUL 12, 2021 8:30AM EDT"
CLSD,https://www.nasdaq.com/press-release/clearside-biomedical-announces-positive-safety-results-from-cohort-1-of-oasis-phase-1,"JUN 9, 2021 8:00AM EDT"
CLSN,https://www.nasdaq.com/press-release/celsion-gmbh-announces-commencement-of-enrollment-in-oxford-universitys-phase-1-study,"JUN 21, 2021 9:20AM EDT"
CLVR,https://www.nasdaq.com/press-release/cannabis-industry-investor-presentations-now-available-for-on-demand-viewing-2021-07,"JUL 6, 2021 8:03AM EDT"
CLVRW,,"JUN 24, 2021 8:05AM EDT"
CLVS,https://www.nasdaq.com/press-release/clovis-oncology-appoints-dr.-ronit-simantov-to-its-board-of-directors-2021-07-12,"JUL 12, 2021 8:00AM EDT"
CMD,https://www.nasdaq.com/press-release/crocs-set-to-join-sp-midcap-400-and-organogenesis-to-join-sp-smallcap-600-2021-05-26,"APR 19, 2021 7:00AM EDT"
CMPI,https://www.nasdaq.com/press-release/checkmate-pharmaceuticals-to-present-at-the-jefferies-2021-virtual-healthcare,"JUL 7, 2021 4:01PM EDT"
CMPS,,"JUL 13, 2021 8:30AM EDT"
CMRX,https://www.nasdaq.com/press-release/chimerix-receives-u.s.-food-and-drug-administration-approval-for-tembexar,"JUN 10, 2021 8:30AM EDT"
CNC,https://www.nasdaq.com/press-release/centene-announces-organizational-enhancements-establishes-the-office-of-the-president,"JUN 28, 2021 7:30AM EDT"
CNCE,https://www.nasdaq.com/press-release/concert-pharmaceuticals-presents-update-on-ctp-543-long-term-extension-study-in,"JUN 15, 2021 7:15AM EDT"
CNMD,https://www.nasdaq.com/press-release/conmed-corporation-to-announce-second-quarter-2021-financial-results-on-july-28-2021,"JUL 8, 2021 8:00AM EDT"
CNSP,https://www.nasdaq.com/press-release/wpd-pharmaceuticals-licensor-receives-fda-fast-track-designation-for-berubicin-for,"MAY 25, 2021 4:05PM EDT"
CNST,https://www.nasdaq.com/press-release/morphosys-announces-expiration-of-the-hart-scott-rodino-waiting-period-for,"MAY 18, 2021 8:35AM EDT"
CNTG,https://www.nasdaq.com/press-release/centogene-announces-shareholders-approve-all-resolutions-at-annual-general-meeting,"JUL 14, 2021 8:30AM EDT"
CO,https://www.nasdaq.com/press-release/global-cord-blood-corporation-reports-financial-results-for-the-fourth-quarter-and-0,"JUL 14, 2021 7:00AM EDT"
COCP,https://www.nasdaq.com/press-release/cocrystal-joins-russell-microcapr-index-2021-06-28,"JUN 21, 2021 7:00AM EDT"
CODX,https://www.nasdaq.com/press-release/co-diagnostics-inc-receives-ce-marking-for-direct-saliva-sars-cov-2-test-2021-06-18,"JUN 21, 2021 4:33PM EDT"
COGT,https://www.nasdaq.com/press-release/cogent-biosciences-to-present-at-ladenburg-thalmann-virtual-healthcare-conference,"JUL 9, 2021 12:48AM EDT"
COLL,https://www.nasdaq.com/press-release/collegium-announces-publication-of-real-world-data-in-journal-of-pain-research-2021,"JUN 28, 2021 8:03AM EDT"
COO,https://www.nasdaq.com/press-release/claritir-1-day-becomes-first-net-plastic-neutral-contact-lens-in-the-u.s.-2021-07-14,"JUN 21, 2021 8:00AM EDT"
CORT,https://www.nasdaq.com/press-release/former-gilead-sciences-executive-amy-e.-flood-joins-corcept-therapeutics-as-chief,"JUL 6, 2021 7:05AM EDT"
CPHI,https://www.nasdaq.com/press-release/china-pharma-to-launch-highly-purified-nmnpqq-product-2021-06-09,"JUL 7, 2021 9:20AM EDT"
CPIX,https://www.nasdaq.com/press-release/vibativr-effectively-helps-treat-secondary-bacterial-infections-in-covid-19-patients,"JUN 14, 2021 8:00AM EDT"
CPRX,https://www.nasdaq.com/press-release/catalyst-pharmaceuticals-expands-leadership-team-with-appointment-of-preethi-sundaram,"JUN 16, 2021 4:13PM EDT"
CRBP,https://www.nasdaq.com/press-release/corbus-pharmaceuticals-announces-topline-results-from-determine-phase-3-study-of,"JUN 30, 2021 4:45PM EDT"
CRDF,https://www.nasdaq.com/press-release/cardiff-oncology-announces-the-appointments-of-katherine-l.-ruffner-m.d.-as-chief,"JUN 30, 2021 8:30AM EDT"
CRHM,https://www.nasdaq.com/press-release/well-health-provides-an-update-on-its-proposed-acquisition-of-crh-medical-2021-04-19,"JUL 7, 2021 8:00AM EDT"
CRIS,https://www.nasdaq.com/press-release/curis-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-07,"JUL 14, 2021 11:00AM EDT"
CRL,https://www.nasdaq.com/press-release/charles-river-laboratories-schedules-second-quarter-2021-earnings-release-and,"JUL 14, 2021 9:00AM EDT"
CRMD,https://www.nasdaq.com/press-release/cormedix-inc.-completes-sale-of-%241.3-million-of-nol-tax-benefits-through-the-new,"JUL 13, 2021 4:01PM EDT"
CRNX,https://www.nasdaq.com/press-release/crinetics-pharmaceuticals-announces-dosing-of-first-patient-in-phase-3-pathfndr-1,"JUL 13, 2021 7:00AM EDT"
CRSP,https://www.nasdaq.com/press-release/crispr-therapeutics-and-capsida-biotherapeutics-announce-strategic-collaboration-to,"JUL 13, 2021 7:00AM EDT"
CRTX,https://www.nasdaq.com/press-release/cortexyme-to-host-two-part-key-opinion-leader-webinar-series-on-atuzaginstat-2021-07,"JUL 8, 2021 7:22PM EDT"
CRVS,https://www.nasdaq.com/press-release/corvus-pharmaceuticals-to-present-at-the-jefferies-virtual-healthcare-conference-2021,"MAY 26, 2021 11:00AM EDT"
CRY,https://www.nasdaq.com/press-release/cryolife-to-participate-in-the-ubs-global-healthcare-virtual-conference-2021-05-18,"JUN 22, 2021 8:30AM EDT"
CSBR,https://www.nasdaq.com/press-release/champions-oncology-to-announce-fourth-quarter-financial-results-on-thursday-july-22,"JUL 1, 2021 4:00PM EDT"
CSII,https://www.nasdaq.com/press-release/cardiovascular-systems-inc.-to-webcast-fiscal-2021-fourth-quarter-earnings-conference,"JUL 12, 2021 5:45AM EDT"
CSTL,https://www.nasdaq.com/press-release/castle-biosciences-is-listed-in-the-houston-chronicles-chron-100-as-one-of-the-100,"JUL 7, 2021 4:30PM EDT"
CSU,https://www.nasdaq.com/press-release/capital-senior-living-announces-may-2021-occupancy-2021-06-21,"JUN 30, 2021 4:01PM EDT"
CTIC,https://www.nasdaq.com/press-release/cti-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-09,"JUL 8, 2021 11:20AM EDT"
CTLT,https://www.nasdaq.com/press-release/cybin-inc.-releases-annual-financials-and-provides-business-highlights-2021-06-28,"JUN 30, 2021 7:35AM EDT"
CTMX,https://www.nasdaq.com/press-release/cytomx-therapeutics-announces-publication-of-first-in-human-data-for-cx-2029-in,"JUN 8, 2021 5:05PM EDT"
CTSO,https://www.nasdaq.com/press-release/cytosorbents-receives-full-fda-approval-of-investigational-device-exemption-ide-for-u,"JUL 14, 2021 11:34AM EDT"
CTXR,https://www.nasdaq.com/press-release/citius-pharmaceuticals-inc.-provides-first-half-2021-business-update-highlights,"JUN 29, 2021 6:58AM EDT"
CTXRW,,"JUL 6, 2021 8:00AM EDT"
CUE,https://www.nasdaq.com/press-release/cue-biopharma-to-present-at-the-upcoming-jmp-securities-life-sciences-conference-2021,"JUN 28, 2021 8:00AM EDT"
CUTR,https://www.nasdaq.com/press-release/cutera-announces-renewal-of-distribution-agreement-with-zo-skin-health-2021-06-16,"JUL 13, 2021 8:30AM EDT"
CVAC,https://www.nasdaq.com/press-release/curevac-final-data-from-phase-2b-3-trial-of-first-generation-covid-19-vaccine,"JUL 1, 2021 4:30PM EDT"
CVET,https://www.nasdaq.com/press-release/covetrus-to-acquire-vcp-market-leading-veterinary-wellness-platform-2021-06-30,"JUN 23, 2021 9:00AM EDT"
CVM,https://www.nasdaq.com/press-release/cel-sci-corporation-issues-letter-to-shareholders-2021-07-07,"JUL 1, 2021 7:00AM EDT"
CVS,https://www.nasdaq.com/press-release/minuteclinic-video-visit-telehealth-offering-now-available-in-nevada-2021-07-14,"JUN 10, 2021 8:04AM EDT"
CWBR,https://www.nasdaq.com/press-release/cohbar-provides-update-on-the-phase-1a-1b-clinical-trial-for-cb4211-under-development,"JUL 6, 2021 8:00AM EDT"
CYAD,https://www.nasdaq.com/press-release/celyad-oncology-to-host-virtual-research-development-webinar-on-july-20th-2021-07-0,"JUL 7, 2021 8:45AM EDT"
CYCC,https://www.nasdaq.com/press-release/cyclacel-announces-dosing-of-first-patient-in-phase-1-2-study-of-oral-fadraciclib-in,"JUL 13, 2021 8:30AM EDT"
CYCCP,https://www.nasdaq.com/press-release/cyclacel-announces-dosing-of-first-patient-in-phase-1-2-study-of-oral-fadraciclib-in,"JUN 28, 2021 8:30AM EDT"
CYCN,https://www.nasdaq.com/press-release/beacon-biosignals-and-cyclerion-therapeutics-announce-strategic-partnership-2021-07,"JUN 25, 2021 7:30AM EDT"
CYH,https://www.nasdaq.com/press-release/community-health-systems-to-participate-in-the-jefferies-virtual-healthcare,"JUL 8, 2021 8:00AM EDT"
CYRX,https://www.nasdaq.com/press-release/cellenkosr-selects-cryoport-to-support-on-demand-flexible-covid-19-therapy-shipments,"JUL 13, 2021 8:00AM EDT"
CYTK,https://www.nasdaq.com/press-release/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-01,"JUL 14, 2021 9:00AM EDT"
DARE,https://www.nasdaq.com/press-release/dare-announces-collaborative-research-agreement-crada-for-the-pivotal-phase-3-study,"JUN 11, 2021 4:35PM EDT"
DBVT,https://www.nasdaq.com/press-release/monthly-information-regarding-the-total-number-of-voting-rights-and-total-number-34,"JUL 13, 2021 8:00AM EDT"
DCPH,https://www.nasdaq.com/press-release/deciphera-announces-first-patient-treated-in-phase-1-study-of-dcc-3116-in-patients,"JUN 15, 2021 8:00AM EDT"
DCTH,https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0,"JUN 23, 2021 7:00AM EDT"
DFFN,https://www.nasdaq.com/press-release/diffusion-pharmaceuticals-reports-positive-trend-in-oxygenation-from-tcom-trial-2021,"JUL 13, 2021 8:10AM EDT"
DFHT,,"JUN 24, 2021 6:50AM EDT"
DFHTU,https://www.nasdaq.com/press-release/deerfield-healthcare-technology-acquisitions-corp.-announces-closing-of-business,"JUL 1, 2021 7:35AM EDT"
DFHTW,,"JUL 7, 2021 8:00AM EDT"
DGX,https://www.nasdaq.com/press-release/quest-diagnostics-named-a-best-place-to-work-for-disability-inclusion-for-fourth,"JUL 12, 2021 8:30AM EDT"
DMAC,https://www.nasdaq.com/press-release/diamedica-therapeutics-announces-positive-interim-results-from-phase-2-redux-study-in,"JUL 2, 2021 8:00AM EDT"
DMTK,https://www.nasdaq.com/press-release/dermtech-announces-new-appointment-of-monica-tellado-to-its-board-of-directors-2021,"MAY 27, 2021 4:30PM EDT"
DNLI,https://www.nasdaq.com/press-release/denali-therapeutics-announces-initiation-of-phase-2-study-by-partner-sanofi-of-ripk1,"JUL 6, 2021 4:15PM EDT"
DRIO,https://www.nasdaq.com/press-release/dariohealth-chief-medical-officer-omar-manejwala-m.d.-to-present-on-the-role-of,"JUN 24, 2021 5:00PM EDT"
DRIOW,,"JUL 14, 2021 8:00AM EDT"
DRNA,https://www.nasdaq.com/press-release/dicerna-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-01,"JUL 12, 2021 7:00AM EDT"
DRRX,https://www.nasdaq.com/press-release/durect-corporation-presents-additional-clinical-data-from-dur-928-phase-1b-trial-in,"JUN 18, 2021 6:00AM EDT"
DTIL,https://www.nasdaq.com/press-release/precision-biosciences-doses-first-patient-in-phase-1-allogeneic-car-t-clinical-trial,"JUN 23, 2021 2:01AM EDT"
DVA,https://www.nasdaq.com/press-release/davita-and-the-national-kidney-foundation-join-forces-to-improve-health-equity-in,"JUN 28, 2021 3:15PM EDT"
DVAX,https://www.nasdaq.com/press-release/dynavax-and-biological-e-announce-commercial-supply-agreement-of-dynavaxs-cpg-1018,"JUN 15, 2021 12:00PM EDT"
DXCM,https://www.nasdaq.com/press-release/dexcom-schedules-second-quarter-2021-earnings-release-and-conference-call-for-july-29,"JUN 30, 2021 9:00AM EDT"
DXR,https://www.nasdaq.com/press-release/american-college-of-cardiology-acc-features-expert-analysis-on-the-importance-of,"MAY 25, 2021 7:00AM EDT"
DYAI,https://www.nasdaq.com/press-release/dyadics-c1-production-platform-utilized-in-zapi-study-published-in-vaccines-a-leading,"JUN 16, 2021 6:30AM EDT"
DYN,https://www.nasdaq.com/press-release/dyne-therapeutics-presents-preclinical-data-from-its-facioscapulohumeral-muscular,"JUL 12, 2021 4:01PM EDT"
DYNT,https://www.nasdaq.com/press-release/dynatronics-corporation-announces-promotion-of-sarah-rome-mealman-to-vice-president,"JUL 6, 2021 12:00PM EDT"
EAR,https://www.nasdaq.com/press-release/eargo-launches-eargo-5-hearing-aid-with-sound-matchtm-technology-2021-07-13,"JUL 13, 2021 8:00AM EDT"
EARS,https://www.nasdaq.com/press-release/auris-medical-announces-publication-of-data-from-preclinical-studies-with-bentriotm,"JUL 12, 2021 8:00AM EDT"
EBS,https://www.nasdaq.com/press-release/covid-19-vaccine-drug-substance-manufactured-by-emergent-biosolutions-authorized-as,"JUN 16, 2021 8:00AM EDT"
ECOR,https://www.nasdaq.com/press-release/electrocore-provides-business-update-and-select-second-quarter-2021-financial,"JUN 15, 2021 4:05PM EDT"
EDAP,https://www.nasdaq.com/press-release/edap-announces-hiring-of-medtech-industry-veteran-ryan-rhodes-as-ceo-of-companys-u.s.,"JUL 14, 2021 8:00AM EDT"
EDIT,https://www.nasdaq.com/press-release/editas-medicine-announces-enrollment-of-the-first-pediatric-cohort-in-the-brilliance,"JUL 14, 2021 8:00AM EDT"
EDSA,https://www.nasdaq.com/press-release/edesa-biotech-extends-dermatitis-study-to-canada-2021-07-13,"JUN 16, 2021 4:01PM EDT"
EGRX,https://www.nasdaq.com/press-release/eagle-pharmaceuticals-announces-fda-maintains-prioritization-of-anda-for-vasopressin,"JUL 14, 2021 8:30AM EDT"
EHC,https://www.nasdaq.com/press-release/encompass-health-announces-plans-to-build-a-40-bed-inpatient-rehabilitation-0,"JUN 1, 2021 4:15PM EDT"
EIGR,https://www.nasdaq.com/press-release/eiger-biopharmaceuticals-to-present-at-ladenburg-thalmann-2021-virtual-healthcare,"JUL 8, 2021 6:00AM EDT"
ELAN,https://www.nasdaq.com/press-release/elanco-confirms-date-and-conference-call-for-second-quarter-2021-financial-results,"JUL 8, 2021 4:05PM EDT"
ELAT,,"JUL 13, 2021 9:00AM EDT"
ELDN,https://www.nasdaq.com/press-release/eledon-pharmaceuticals-appoints-jan-hillson-m.d.-to-its-board-of-directors-2021-07-02,"JUN 14, 2021 6:55AM EDT"
ELMD,https://www.nasdaq.com/press-release/electromed-inc.-announces-authorization-of-%243.0-million-stock-repurchase-program-2021,"JUL 7, 2021 4:01PM EDT"
ELOX,https://www.nasdaq.com/press-release/eloxx-pharmaceuticals-provides-enrollment-update-for-ongoing-phase-2-clinical-studies,"JUN 25, 2021 1:39PM EDT"
ENDP,https://www.nasdaq.com/press-release/endo-to-announce-second-quarter-2021-financial-results-2021-06-24,"JUN 15, 2021 8:00AM EDT"
ENLV,https://www.nasdaq.com/press-release/enlivex-to-present-at-the-ards-drug-development-summit-2021-2021-07-14,"JUL 8, 2021 8:30AM EDT"
ENOB,https://www.nasdaq.com/press-release/enochian-biosciences-announces-fda-acceptance-of-pre-ind-request-for-potential-cure,"JUL 12, 2021 4:01PM EDT"
ENSG,https://www.nasdaq.com/press-release/the-ensign-group-inc.-declares-quarterly-dividend-of-%240.0525-per-share-2021-06-18,"JUN 24, 2021 7:01AM EDT"
ENTA,https://www.nasdaq.com/press-release/enanta-pharmaceuticals-presents-new-data-for-edp-721-an-oral-hepatitis-b-virus-rna,"JUN 29, 2021 5:30PM EDT"
ENTX,https://www.nasdaq.com/press-release/entera-bio-to-conduct-conference-call-on-june-30-to-discuss-phase-2-results-for-eb613,"JUL 12, 2021 7:00AM EDT"
ENTXW,,"JUL 9, 2021 8:36AM EDT"
ENZ,https://www.nasdaq.com/press-release/enzo-biochem-announces-online-service-with-trustassure-to-schedule-timely-pcr-testing,"MAY 13, 2021 7:00AM EDT"
EOLS,https://www.nasdaq.com/press-release/evolus-announces-appointment-of-david-k.-erickson-as-vice-president-investor,"MAY 10, 2021 8:00AM EDT"
EPIX,https://www.nasdaq.com/press-release/essa-pharma-to-present-at-the-jefferies-virtual-healthcare-conference-2021-05-25,"JUL 12, 2021 4:30PM EDT"
EPZM,https://www.nasdaq.com/press-release/epizyme-launches-ezh2now-testing-program-with-quest-diagnostics-for-relapsed-or,"JUL 13, 2021 3:51AM EDT"
EQ,https://www.nasdaq.com/press-release/equillium-announces-plans-to-initiate-phase-3-pivotal-study-of-itolizumab-in-first,"JUN 14, 2021 7:05AM EDT"
ERYP,https://www.nasdaq.com/press-release/monthly-information-related-to-total-number-of-voting-rights-and-shares-composing-32,"JUN 14, 2021 7:00AM EDT"
ESPR,https://www.nasdaq.com/press-release/esperion-to-report-second-quarter-2021-financial-results-august-3-2021-2021-07-13,"MAY 13, 2021 7:30AM EDT"
ESTA,https://www.nasdaq.com/press-release/establishment-labs-announces-departure-of-cfo-and-appointment-of-raj-denhoy-as,"APR 16, 2021 8:25AM EDT"
ETNB,https://www.nasdaq.com/press-release/89bio-to-participate-in-upcoming-investor-conferences-2021-06-16,"JUN 4, 2021 3:58PM EDT"
ETON,https://www.nasdaq.com/press-release/eton-pharmaceuticals-acquires-u.s.-and-canadian-rights-to-zeneor-hydrocortisone,"JUN 30, 2021 4:01PM EDT"
ETTX,https://www.nasdaq.com/press-release/entasis-therapeutics-expands-executive-leadership-team-with-the-appointment-of-anna,"JUL 9, 2021 8:00AM EDT"
EVFM,https://www.nasdaq.com/press-release/early-look-at-second-quarter-metrics-for-phexxir-reveals-strong-growth-2021-07-14,"JUN 24, 2021 7:00AM EDT"
EVLO,https://www.nasdaq.com/press-release/evelo-biosciences-announces-grant-of-inducement-award-2021-06-16,"JUL 7, 2021 8:00AM EDT"
EVOK,https://www.nasdaq.com/press-release/evoke-pharma-launches-gimotir-patient-and-physician-experience-program-2021-07-14,"JUL 6, 2021 8:00AM EDT"
EW,https://www.nasdaq.com/press-release/edwards-receives-clearance-for-hypotension-prediction-index-software-for-noninvasive,"APR 14, 2021 4:40PM EDT"
EXAS,https://www.nasdaq.com/press-release/exact-sciences-schedules-second-quarter-2021-earnings-call-2021-07-08,"JUL 9, 2021 8:00AM EDT"
EXEL,https://www.nasdaq.com/press-release/exelixis-to-present-at-the-virtual-william-blair-biotech-focus-conference-on-july-15,"JUL 14, 2021 7:30AM EDT"
EYE,https://www.nasdaq.com/press-release/national-vision-expands-annual-continuing-education-symposium-to-three-regional,"JUL 8, 2021 9:21AM EDT"
EYEG,https://www.nasdaq.com/press-release/eyegate-pharma-announces-first-patient-dosed-for-pp-001-in-a-phase-2-proof-of-concept,"JUL 9, 2021 8:00AM EDT"
EYEN,https://www.nasdaq.com/press-release/eyenovia-to-participate-in-two-upcoming-investor-conferences-2021-07-07,"MAR 23, 2021 8:30AM EDT"
EYES,https://www.nasdaq.com/press-release/second-sight-medical-products-announces-closing-of-public-offering-2021-06-25,"JUL 9, 2021 8:00AM EDT"
EYESW,,"JUN 17, 2021 4:30PM EDT"
FATE,https://www.nasdaq.com/press-release/fate-therapeutics-appoints-mark-plavsic-dvm-phd-rac-as-chief-technical-officer-2021,"JUL 13, 2021 8:05AM EDT"
FBIO,https://www.nasdaq.com/press-release/checkpoint-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare,"JUN 14, 2021 8:05AM EDT"
FBIOP,,"JUL 12, 2021 7:30AM EDT"
FBRX,https://www.nasdaq.com/press-release/forte-biosciences-inc.-reports-inducement-grants-under-nasdaq-listing-rules-2021-07-0,"JUL 14, 2021 2:00AM EDT"
FDMT,https://www.nasdaq.com/press-release/4d-molecular-therapeutics-announces-rare-disease-ophthalmology-product-candidate,"MAY 13, 2021 7:50AM EDT"
FENC,https://www.nasdaq.com/press-release/fennec-announces-results-of-annual-meeting-2021-06-29,"JUL 10, 2021 5:10AM EDT"
FGEN,https://www.nasdaq.com/press-release/fibrogen-appoints-john-hunter-ph.d.-as-chief-scientific-officer-2021-07-12,"JUN 8, 2021 6:00AM EDT"
FHTX,https://www.nasdaq.com/press-release/foghorn-therapeutics-to-participate-at-the-william-blair-biotech-focus-conference,"JUL 13, 2021 8:00AM EDT"
FIXX,https://www.nasdaq.com/press-release/homology-medicines-announces-presentations-on-its-expanding-genetic-medicines,"JUL 12, 2021 9:00AM EDT"
FLGT,https://www.nasdaq.com/press-release/fulgent-genetics-announces-incremental-strategic-investment-in-chinese-joint-venture,"JUL 6, 2021 2:04PM EDT"
FLXN,https://www.nasdaq.com/press-release/flexion-therapeutics-announces-appointment-of-utpal-koppikar-to-its-board-of,"JUN 23, 2021 7:00AM EDT"
FMS,https://www.nasdaq.com/press-release/xenios-ag-receives-approval-in-china-for-ecmo-devices-2021-07-13,"MAY 4, 2021 4:15PM EDT"
FMTX,https://www.nasdaq.com/press-release/forma-therapeutics-announces-appointment-of-industry-veteran-john-e.-bishop-ph.d.-as,"JUN 22, 2021 4:05PM EDT"
FOLD,https://www.nasdaq.com/press-release/amicus-therapeutics-appoints-eiry-w.-roberts-m.d.-to-its-board-of-directors-2021-06,"JUL 13, 2021 7:30AM EDT"
FONR,https://www.nasdaq.com/press-release/fonar-announces-3rd-quarter-and-nine-months-results-for-fiscal-2021-income-increases,"JUL 9, 2021 4:10PM EDT"
FPRX,https://www.nasdaq.com/press-release/amgen-successfully-completes-acquisition-of-five-prime-therapeutics-2021-04-16,"FEB 25, 2021 4:05PM EST"
FREQ,https://www.nasdaq.com/press-release/notice-of-lead-plaintiff-deadline-for-shareholders-in-the-frequency-therapeutics-inc.,"JUN 23, 2021 8:30AM EDT"
FRLN,https://www.nasdaq.com/press-release/freeline-announces-executive-leadership-changes-2021-06-30,"JUL 7, 2021 7:01AM EDT"
FSTX,https://www.nasdaq.com/press-release/f-star-therapeutics-to-present-at-upcoming-investor-conferences-2021-07-09,"JUL 7, 2021 9:00AM EDT"
FULC,https://www.nasdaq.com/press-release/fulcrum-therapeutics-announces-results-from-redux4-trial-with-losmapimod-in,"MAY 12, 2021 7:30AM EDT"
FUSN,https://www.nasdaq.com/press-release/fusion-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c4,"JUN 2, 2021 8:30AM EDT"
FVE,https://www.nasdaq.com/press-release/five-star-senior-living-inc.-second-quarter-2021-conference-call-scheduled-for,"JUL 14, 2021 10:00AM EDT"
FWP,https://www.nasdaq.com/press-release/forward-pharma-reports-financial-and-operational-results-from-the-year-ended-0,"JUL 14, 2021 8:00AM EDT"
GALT,https://www.nasdaq.com/press-release/galectin-therapeutics-announces-positive-top-line-results-from-a-phase-1b-clinical,"JUL 14, 2021 8:00AM EDT"
GBIO,https://www.nasdaq.com/press-release/generation-bio-announces-plan-to-scale-next-generation-rapid-enzymatic-manufacturing,"JUN 23, 2021 8:00AM EDT"
GBS,https://www.nasdaq.com/press-release/gbs-awarded-%244.7-million-australian-federal-government-science-grant-to-manufacture,"JUN 28, 2021 7:00AM EDT"
GBT,https://www.nasdaq.com/press-release/gbt-announces-new-employment-inducement-grants-2021-07-09,"JUN 29, 2021 1:04PM EDT"
GEN           ,https://www.nasdaq.com/press-release/highly-regarded-turnaround-specialist-harry-wilson-appointed-ceo-of-genesis,"JUL 13, 2021 8:30AM EDT"
GENE,https://www.nasdaq.com/press-release/genetic-technologies-continues-to-break-new-ground-as-it-advances-development-of-its,"JUL 2, 2021 7:30PM EDT"
GERN,https://www.nasdaq.com/press-release/geron-announces-publication-of-imbark-phase-2-data-in-journal-of-clinical-oncology,"MAY 5, 2021 9:15AM EDT"
GH,https://www.nasdaq.com/press-release/guardant-health-to-report-second-quarter-financial-results-on-august-5-2021-2021-07,"MAY 14, 2021 4:45PM EDT"
GHSI,https://www.nasdaq.com/press-release/guardion-health-sciences-to-be-added-to-the-russell-3000-index-2021-06-14,"MAY 5, 2021 8:00AM EDT"
GILD,https://www.nasdaq.com/press-release/gilead-to-present-new-data-at-ias-2021-demonstrating-the-companys-commitment-to,"JUL 9, 2021 4:10PM EDT"
GKOS,https://www.nasdaq.com/press-release/glaukos-comments-on-the-centers-for-medicare-and-medicaid-services-2022-proposed,"JUN 22, 2021 1:48PM EDT"
GLMD,https://www.nasdaq.com/press-release/galmed-pharmaceuticals-provides-business-updates-and-reports-first-quarter-2021,"JUN 4, 2021 4:00PM EDT"
GLPG,https://www.nasdaq.com/press-release/galapagos-announces-new-data-supporting-rapid-symptom-improvement-and-sustained,"JUL 1, 2021 4:59PM EDT"
GLSI,https://www.nasdaq.com/press-release/greenwich-lifesciences-set-to-join-russell-2000r-index-2021-06-08,"JUL 13, 2021 2:00AM EDT"
GLTO,https://www.nasdaq.com/press-release/galecto-resumes-recruitment-in-phase-2b-global-galactic-1-trial-of-gb0139-for,"APR 21, 2021 7:00AM EDT"
GLYC,https://www.nasdaq.com/press-release/glycomimetics-announces-initiation-of-clinical-trial-evaluating-uproleselan-in,"JUL 13, 2021 8:00AM EDT"
GMAB,https://www.nasdaq.com/press-release/capital-increase-in-genmab-as-a-result-of-employee-warrant-exercise-2021-07-06,"JUL 9, 2021 6:30AM EDT"
GMDA,https://www.nasdaq.com/press-release/gamida-cell-announces-publication-in-blood-the-journal-of-the-american-society-of,"JUL 13, 2021 8:57AM EDT"
GMED,https://www.nasdaq.com/press-release/globus-medical-reports-first-quarter-2021-results-2021-05-04,"JUL 8, 2021 9:05AM EDT"
GMTX,https://www.nasdaq.com/press-release/gemini-therapeutics-announces-initial-data-from-its-ongoing-phase-2a-study-of-gem103,"JUL 6, 2021 4:10PM EDT"
GNCA,https://www.nasdaq.com/press-release/genocea-doses-first-patient-in-phase-1-2a-titan-clinical-trial-for-gen-011-neoantigen,"JUL 14, 2021 8:00AM EDT"
GNFT,https://www.nasdaq.com/press-release/genfit%3A-half-year-report-of-liquidity-contract-with-credit-industriel-et-commercial-3,"JUL 14, 2021 2:00AM EDT"
GNMK,https://www.nasdaq.com/press-release/genmark-diagnostics-reports-fourth-quarter-and-full-year-2020-results-2021-02-25,"JUN 10, 2021 7:30AM EDT"
GNPX,https://www.nasdaq.com/press-release/genprex-announces-initiation-of-its-phase-1-2-acclaim-1-clinical-trial-for-reqorsatm,"JUL 13, 2021 8:15AM EDT"
GOSS,https://www.nasdaq.com/press-release/gossamer-bio-announces-gb004-clinical-trial-data-presentations-at-2021-virtual,"JUL 12, 2021 6:59AM EDT"
GOVX,https://www.nasdaq.com/press-release/geovax-announces-issuance-of-hepatitis-b-vaccine-patent-2021-07-07,"JUN 29, 2021 8:05AM EDT"
GOVXW,,"JUN 17, 2021 4:01PM EDT"
GRAY,https://www.nasdaq.com/press-release/graybug-vision-announces-first-quarter-2021-financial-results-and-recent-corporate,"JUL 6, 2021 8:30AM EDT"
GRCL,https://www.nasdaq.com/press-release/gracell-biotechnologies-reschedules-clinical-update-conference-call-and-webcast-to,"JUL 12, 2021 4:05PM EDT"
GRFS,https://www.nasdaq.com/press-release/gigagen-publishes-research-describing-novel-mechanism-of-action-and-therapeutic,"JUN 21, 2021 12:06PM EDT"
GRNV,https://www.nasdaq.com/press-release/li-cycle-and-helbiz-partner-to-advance-battery-recycling-in-micro-mobility-2021-07-14,"JUL 13, 2021 8:00AM EDT"
GRNVR,,"JUN 30, 2021 8:00AM EDT"
GRNVU,https://www.nasdaq.com/press-release/li-cycle-and-helbiz-partner-to-advance-battery-recycling-in-micro-mobility-2021-07-14,"JUN 28, 2021 7:30AM EDT"
GRNVW,,"JUN 3, 2021 9:00AM EDT"
GRTS,https://www.nasdaq.com/press-release/gritstone-announces-management-changes-including-the-appointment-of-celia-economides,"JUL 12, 2021 9:00AM EDT"
GRTX,https://www.nasdaq.com/press-release/galera-announces-completion-of-enrollment-in-pivotal-455-patient-phase-3-trial-of,"JUL 8, 2021 8:00AM EDT"
GSK,https://www.nasdaq.com/press-release/tumsr-fuels-the-autoburn-a-road-trip-to-americas-spiciest-destinations-with-hot-food,"JUL 8, 2021 8:30AM EDT"
GTH,https://www.nasdaq.com/press-release/genetron-health-receives-ce-mark-for-8-gene-lung-cancer-assay-and-provides-fda,"JUL 8, 2021 4:15PM EDT"
GTHX,https://www.nasdaq.com/press-release/g1-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07,"JUN 14, 2021 8:00AM EDT"
GWPH,https://www.nasdaq.com/press-release/jazz-pharmaceuticals-completes-acquisition-of-gw-pharmaceuticals-plc-2021-05-05,"JUL 7, 2021 7:00AM EDT"
GXGX,https://www.nasdaq.com/press-release/gx-acquisition-corp.-announces-shareholder-approval-of-extension-proposal-2021-05-14,"JUL 1, 2021 8:43AM EDT"
GXGXU,https://www.nasdaq.com/press-release/celularity-enters-into-multi-year-strategic-partnership-with-palantir-technologies,"JUN 21, 2021 8:00AM EDT"
GXGXW,,"MAY 6, 2021 4:05PM EDT"
HAE,https://www.nasdaq.com/press-release/c-o-r-r-e-c-t-i-o-n-haemonetics-corporation-2021-07-09,"MAY 18, 2021 4:15PM EDT"
HALO,https://www.nasdaq.com/press-release/halozyme-announces-janssen-receives-european-marketing-authorizations-for-darzalexr,"MAY 17, 2021 8:00AM EDT"
HARP,https://www.nasdaq.com/press-release/harpoon-therapeutics-provides-progress-update-for-tritacr-clinical-programs-and,"JUN 30, 2021 4:05PM EDT"
HCA,https://www.nasdaq.com/press-release/hca-healthcare-completes-previously-announced-purchase-of-majority-stake-in-brookdale,"JUL 12, 2021 4:11PM EDT"
HCM,https://www.nasdaq.com/press-release/hutchmed-announces-first-commercial-sale-of-orpathysr-in-china-triggering-a-us%2425,"JUN 3, 2021 7:01AM EDT"
HCSG,https://www.nasdaq.com/press-release/healthcare-services-group-inc.-reports-q1-2021-results-2021-04-21,"JUN 18, 2021 6:45PM EDT"
HEC,,"JUL 9, 2021 9:00AM EDT"
HECCU,https://www.nasdaq.com/press-release/talkspace-a-leading-virtual-behavioral-healthcare-company-completes-merger-with,"JUL 13, 2021 9:00AM EDT"
HECCW,,"JUN 4, 2021 9:05AM EDT"
HEPA,https://www.nasdaq.com/press-release/hepion-pharmaceuticals-announces-positive-topline-data-from-phase-2a-ambition-nash,"JUL 1, 2021 4:30PM EDT"
HGEN,https://www.nasdaq.com/press-release/uks-mhra-accepts-humanigens-submission-of-lenzilumab-for-marketing-authorization-in,"JUL 13, 2021 8:00AM EDT"
HIMS,https://www.nasdaq.com/press-release/the-pandemics-impact-on-americans-mental-health%3A-new-hims-hers-survey-shows-70-remain,"JUL 6, 2021 7:00AM EDT"
HJLI,https://www.nasdaq.com/press-release/hancock-jaffe-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference-2021-07,"JUL 13, 2021 10:58PM EDT"
HJLIW,,"MAY 13, 2021 6:00AM EDT"
HLF,https://www.nasdaq.com/press-release/herbalife-nutrition-ltd.-announces-second-quarter-2021-earnings-release-date-and,"JUL 7, 2021 3:00AM EDT"
HNGR,https://www.nasdaq.com/press-release/hanger-announces-date-of-2021-second-quarter-earnings-release-and-conference-call,"JUL 2, 2020 7:00AM EDT"
HOLX,https://www.nasdaq.com/press-release/hologic-obtains-european-ce-mark-for-use-of-saliva-samples-with-covid-19-test-2021-07,"JUL 12, 2021 6:30AM EDT"
HOOK,https://www.nasdaq.com/press-release/hookipa-pharma-to-participate-in-upcoming-investor-conferences-in-june-2021-06-10,"JUN 18, 2021 4:05PM EDT"
HOTH,https://www.nasdaq.com/press-release/hoth-therapeutics-announces-positive-confirmatory-results-from-in-vivo-model-of-ht,"JUN 1, 2021 7:31AM EDT"
HRC,https://www.nasdaq.com/press-release/hillrom-comments-on-delaware-court-of-chancery-ruling-2021-07-12,"JUN 21, 2021 4:05PM EDT"
HRMY,https://www.nasdaq.com/press-release/harmony-biosciences-initiates-a-phase-2-clinical-trial-in-myotonic-dystrophy-2021-06,"JUN 25, 2021 7:42AM EDT"
HROW,https://www.nasdaq.com/press-release/harrow-health-announces-closing-of-%2420-million-aggregate-principal-amount-offering-of,"JUN 14, 2021 8:35AM EDT"
HRTX,https://www.nasdaq.com/press-release/heron-therapeutics-announces-340b-prime-vendor-contract-with-apexus-for-zynreleftm,"JUN 30, 2021 6:33AM EDT"
HSDT,https://www.nasdaq.com/press-release/helius-medical-technologies-inc.-to-present-at-two-upcoming-investor-conferences-in,"JUL 14, 2021 6:00AM EDT"
HSIC,https://www.nasdaq.com/press-release/henry-schein-opens-customer-assistance-hotline-in-response-to-tropical-storm,"JUN 29, 2021 7:00AM EDT"
HSKA,https://www.nasdaq.com/press-release/heska-second-quarter-2021-financial-results-and-earnings-call-scheduled-for-august-3,"JUL 14, 2021 9:02AM EDT"
HSTO,https://www.nasdaq.com/press-release/histogen-announces-initiation-of-hst-003-phase-1-2-trial-for-knee-cartilage,"JUL 12, 2021 8:00AM EDT"
HTBX,https://www.nasdaq.com/press-release/heat-biologics-joins-russell-microcapr-index-2021-06-28,"JUN 8, 2021 8:00AM EDT"
HUGE,https://www.nasdaq.com/press-release/fsd-pharma-inc.-appoints-a-new-independent-director-2021-06-03,"JUL 8, 2021 8:00AM EDT"
HUM,https://www.nasdaq.com/press-release/louisville-nonprofits-receive-%241.7-million-through-the-humana-foundations-community,"JUL 6, 2021 8:00AM EDT"
HZNP,https://www.nasdaq.com/press-release/horizon-therapeutics-plc-to-release-second-quarter-2021-financial-results-and-host,"MAY 20, 2021 9:40AM EDT"
IART,https://www.nasdaq.com/press-release/integra-lifesciences-to-host-second-quarter-2021-financial-results-conference-call-on,"JUL 14, 2021 8:30AM EDT"
IBIO,https://www.nasdaq.com/press-release/ibio-establishes-oncology-drug-discovery-pipeline-with-three-new-antibody-programs,"JUL 13, 2021 7:30AM EDT"
ICAD,https://www.nasdaq.com/press-release/icads-profound-ai-for-digital-breast-tomosynthesis-version-3.0-receives-ce-mark,"JUL 13, 2021 6:59AM EDT"
ICCC,https://www.nasdaq.com/press-release/immucell-announces-strong-preliminary-unaudited-sales-results-for-second-quarter-of,"JUN 29, 2021 3:38PM EDT"
ICLR,https://www.nasdaq.com/press-release/icon-acquisition-creates-world-leading-healthcare-intelligence-and-clinical-research,"JUN 22, 2021 8:28AM EDT"
ICPT,https://www.nasdaq.com/press-release/intercept-to-present-new-nash-and-pbc-data-at-the-digital-international-liver-0,"JUL 12, 2021 1:00AM EDT"
ICUI,https://www.nasdaq.com/press-release/icu-medical-inc.-announces-first-quarter-2021-results-2021-05-06,"JUL 13, 2021 4:15PM EDT"
IDRA,https://www.nasdaq.com/press-release/idera-pharmaceuticals-announces-corporate-updates-2021-05-18,"MAY 11, 2021 4:05PM EDT"
IDXG,https://www.nasdaq.com/press-release/interpace-pharma-solutions-announces-new-capability-in-spatial-biology-precision,"JUL 7, 2021 7:00AM EDT"
IDXX,https://www.nasdaq.com/press-release/idexx-laboratories-to-release-2021-second-quarter-financial-results-2021-06-30,"JUL 14, 2021 6:00AM EDT"
IDYA,https://www.nasdaq.com/press-release/ideaya-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of,"JUN 16, 2021 7:45AM EDT"
IGMS,https://www.nasdaq.com/press-release/igm-biosciences-announces-expansion-of-igm-platform-into-infectious-diseases,"JUL 12, 2021 10:09PM EDT"
IKT,https://www.nasdaq.com/press-release/inhibikase-therapeutics-announces-closing-of-follow-on-offering-of-common-stock-2021,"MAY 13, 2021 4:05PM EDT"
IMAB,https://www.nasdaq.com/press-release/abl-bio-announces-publication-of-preclinical-data-demonstrating-safety-and-efficacy,"APR 26, 2021 8:45AM EDT"
IMAC,https://www.nasdaq.com/press-release/imac-holdings-inc.-announces-initiation-of-second-cohort-of-its-phase-1-clinical,"JUN 7, 2021 8:00AM EDT"
IMACW,,"JUN 30, 2021 6:00AM EDT"
IMCR,https://www.nasdaq.com/press-release/immunocore-presents-clinical-data-further-characterizing-the-overall-survival-benefit,"JUL 8, 2021 10:03AM EDT"
IMGN,https://www.nasdaq.com/press-release/immunogen-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-01,"JUL 1, 2021 6:30PM EDT"
IMMP,https://www.nasdaq.com/press-release/immutep-quarterly-activities-report-2021-07-13,"JUN 28, 2021 9:34AM EDT"
IMNM,https://www.nasdaq.com/press-release/immunome-to-present-at-the-ladenburg-thalmann-2021-healthcare-conference-2021-07-06,"JUL 14, 2021 8:30AM EDT"
IMRA,https://www.nasdaq.com/press-release/imara-announces-pricing-of-public-offering-2021-07-13,"JUL 13, 2021 4:15PM EDT"
IMRN,https://www.nasdaq.com/press-release/imm124e-may-offer-a-new-modality-for-inhibition-of-sars-cov-2-2021-05-13,"JUL 7, 2021 8:00AM EDT"
IMRNW,,"JUL 1, 2021 7:59PM EDT"
IMTX,https://www.nasdaq.com/press-release/biocopy-ag-and-immatics-enter-into-a-collaboration-to-characterize-t-cell-receptor,"JUN 3, 2021 4:10PM EDT"
IMTXW,https://www.nasdaq.com/press-release/immatics-announces-completion-of-business-combination-and-listing-on-nasdaq-2020-07-0,"JUN 18, 2021 4:01PM EDT"
IMUX,https://www.nasdaq.com/press-release/immunic-inc.-to-host-virtual-rd-day-today-to-provide-an-update-on-the-preclinical-and,"JUL 13, 2021 6:30AM EDT"
IMV,https://www.nasdaq.com/press-release/imv-announces-annual-and-special-meeting-of-shareholders-voting-results-2021-06-18,"MAY 25, 2021 4:01PM EDT"
IMVT,https://www.nasdaq.com/press-release/immunovant-provides-corporate-updates-and-reports-financial-results-for-the-quarter,"JUL 12, 2021 4:05PM EDT"
INBX,https://www.nasdaq.com/press-release/inhibrx-initiates-a-potential-registration-enabling-phase-2-study-of-inbrx-109-in,"JUN 10, 2021 7:04AM EDT"
INCY,https://www.nasdaq.com/press-release/incyte-and-morphosys-announce-positive-chmp-opinion-for-tafasitamab-in-combination,"JUN 16, 2021 6:30AM EDT"
INFI,https://www.nasdaq.com/press-release/infinity-to-present-at-the-keystone-symposia-precision-oncology-meeting-2021-06-14,"JUN 10, 2021 7:30AM EDT"
INFU,https://www.nasdaq.com/press-release/infusystem-announces-%2420-million-stock-repurchase-program-2021-06-30,"JUN 2, 2021 7:00AM EDT"
INGN,https://www.nasdaq.com/press-release/inogen-to-announce-second-quarter-2021-financial-results-on-august-4-2021-2021-07-14,"JUN 18, 2021 9:15AM EDT"
INM,https://www.nasdaq.com/press-release/inmed-pharmaceuticals-announces-%2412-million-private-placement-priced-at-the-market,"JUN 8, 2021 4:01PM EDT"
INMB,https://www.nasdaq.com/press-release/inmune-bio-inc.-announces-%2440-million-registered-direct-offering-2021-07-14,"JUL 7, 2021 4:05PM EDT"
INMD,https://www.nasdaq.com/press-release/inmode-expects-record-second-quarter-2021-revenue-between-%2486.5m-%2487.0m-increasing,"MAY 20, 2021 7:00PM EDT"
INO,https://www.nasdaq.com/press-release/inovio-expands-partnership-with-advaccine-to-conduct-global-phase-3-efficacy-trial-of,"JUL 1, 2021 8:00AM EDT"
INSM,https://www.nasdaq.com/press-release/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-08,"JUL 2, 2021 4:23PM EDT"
INSP,https://www.nasdaq.com/press-release/inspire-medical-systems-inc.-to-report-second-quarter-2021-financial-results-on,"MAY 12, 2021 4:02PM EDT"
INVA,https://www.nasdaq.com/press-release/innoviva-announces-strategic-repurchase-of-gsks-equity-stake-2021-05-20,"MAY 26, 2021 8:00AM EDT"
INVO,https://www.nasdaq.com/press-release/invo-bioscience-appoints-barbara-levy-as-senior-vp-global-clinical-integration-2021,"JUN 22, 2021 4:01PM EDT"
INZY,https://www.nasdaq.com/press-release/inozyme-pharma-announces-appointment-of-gayle-gironda-as-senior-vice-president-human,"JUN 23, 2021 8:46AM EDT"
IONS,https://www.nasdaq.com/press-release/ionis-enters-exclusive-licensing-agreement-with-bicycle-therapeutics-aimed-at-further,"JUL 1, 2021 4:15PM EDT"
IOVA,https://www.nasdaq.com/press-release/iovance-biotherapeutics-to-host-conference-call-and-webcast-to-discuss-clinical-data,"JUL 1, 2021 8:00AM EDT"
IPA,https://www.nasdaq.com/press-release/eurofins-discovery-and-immunoprecise-announce-collaboration-to-expand-their-antibody,"JUL 6, 2021 7:30AM EDT"
IPHA,https://www.nasdaq.com/press-release/number-of-shares-and-voting-rights-of-innate-pharma-as-of-july-1-2021-2021-07-12,"JUL 12, 2021 8:00AM EDT"
IQV,https://www.nasdaq.com/press-release/iqvia-to-announce-second-quarter-2021-results-on-july-27-2021-2021-07-13,"JUN 30, 2021 10:00AM EDT"
IRIX,https://www.nasdaq.com/press-release/iridex-announces-first-quarter-2021-financial-results-2021-05-11,"JUL 8, 2021 7:01AM EDT"
IRMD,https://www.nasdaq.com/press-release/iradimed-corporation-to-hold-2021-second-quarter-financial-results-conference-call-on,"JUN 14, 2021 5:08PM EDT"
IRTC,https://www.nasdaq.com/press-release/irhythmr-technologies-comments-on-the-centers-for-medicare-and-medicaid-services-2022,"JUL 7, 2021 11:30AM EDT"
IRWD,https://www.nasdaq.com/press-release/ironwood-pharmaceuticals-announces-that-the-american-journal-of-gastroenterology,"JUL 12, 2021 6:52AM EDT"
ISEE,https://www.nasdaq.com/press-release/iveric-bio-inc.-announces-pricing-of-%24100-million-public-offering-of-common-stock,"JUL 13, 2021 8:00AM EDT"
ISR,https://www.nasdaq.com/press-release/isoray-announces-third-quarter-fiscal-2021-financial-results-2021-05-13,"JUN 22, 2021 8:00AM EDT"
ISRG,https://www.nasdaq.com/press-release/intuitive-appoints-dr.-monica-p.-reed-to-its-board-of-directors-2021-04-26,"JUL 13, 2021 7:05AM EDT"
ITCI,https://www.nasdaq.com/press-release/caplytar-lumateperone-schizophrenia-safety-and-tolerability-profile-published-in-the,"APR 29, 2021 4:05PM EDT"
ITMR,https://www.nasdaq.com/press-release/itamar-medical-to-present-at-the-ladenburg-thalmann-annual-healthcare-conference-on,"JUN 2, 2021 9:00AM EDT"
ITOS,https://www.nasdaq.com/press-release/iteos-therapeutics-to-present-at-william-blair-biotech-focus-conference-2021-2021-07,"FEB 16, 2021 6:00AM EST"
ITRM,https://www.nasdaq.com/press-release/iterum-therapeutics-provides-regulatory-update-2021-07-01,"JUL 2, 2021 6:59AM EDT"
IVA,,"JUL 7, 2021 7:00AM EDT"
IVC,https://www.nasdaq.com/press-release/invacare-corporation-to-participate-in-the-21st-annual-cjs-securities-new-ideas,"MAY 28, 2021 6:00AM EDT"
JAGX,https://www.nasdaq.com/press-release/jaguar-health-announces-completion-of-investigator-initiated-phase-2-halt-d-study,"JUL 8, 2021 8:00AM EDT"
JAZZ,https://www.nasdaq.com/press-release/jazz-pharmaceuticals-announces-rylazetm-asparaginase-erwinia-chrysanthemi-recombinant,"JUN 28, 2021 9:00AM EDT"
JNCE,https://www.nasdaq.com/press-release/jounce-therapeutics-to-participate-in-william-blairs-biotech-focus-conference-2021-07,"JUL 13, 2021 9:25AM EDT"
JNJ,https://www.nasdaq.com/press-release/positive-new-data-for-johnson-johnson-single-shot-covid-19-vaccine-on-activity,"MAY 7, 2021 8:45AM EDT"
JWS,https://www.nasdaq.com/press-release/cano-health-closes-business-combination-with-jaws-acquisition-corp.-and-will-begin,"JUL 14, 2021 6:45AM EDT"
KALA,https://www.nasdaq.com/press-release/kala-pharmaceuticals-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-2021-3,"JUL 13, 2021 11:03PM EDT"
KALV,https://www.nasdaq.com/press-release/kalvista-pharmaceuticals-provides-operational-update-and-fiscal-year-financial-0,"JUL 9, 2021 4:11PM EDT"
KDMN,https://www.nasdaq.com/press-release/kadmon-to-present-at-upcoming-investor-conferences-2021-05-25,"JUL 12, 2021 6:26PM EDT"
KDNY,https://www.nasdaq.com/press-release/chinook-therapeutics-to-present-at-the-william-blair-biotech-focus-conference-2021,"MAY 24, 2021 8:00AM EDT"
KIDS,https://www.nasdaq.com/press-release/orthopediatrics-corp.-announces-launch-of-next-generation-cannulated-screw-system,"JUL 14, 2021 8:00AM EDT"
KIN,https://www.nasdaq.com/press-release/elanco-announces-agreement-to-acquire-kindred-biosciences-2021-06-16,"JUL 8, 2021 7:00AM EDT"
KLDO,https://www.nasdaq.com/press-release/kaleido-biosciences-to-participate-in-the-jmp-securities-life-sciences-conference,"JUL 6, 2021 8:00AM EDT"
KMDA,https://www.nasdaq.com/press-release/kedrion-and-kamada-announce-fda-approval-of-kedrabr-label-update-confirming-safety,"JUL 7, 2021 7:00AM EDT"
KMPH,https://www.nasdaq.com/press-release/kempharm-announces-exercise-of-existing-warrants-and-issuance-of-warrants-in-private,"JUN 7, 2021 6:00AM EDT"
KNSA,https://www.nasdaq.com/press-release/kiniksa-announces-issuance-of-u.s.-patent-for-treatment-of-recurrent-pericarditis,"JUL 8, 2021 4:01PM EDT"
KNTE,https://www.nasdaq.com/press-release/kinnate-biopharma-inc.-to-participate-in-the-william-blair-biotech-focus-conference,"JUN 28, 2021 8:00AM EDT"
KOD,https://www.nasdaq.com/press-release/kodiak-sciences-to-present-at-upcoming-conferences-2021-05-20,"JUN 21, 2021 9:05AM EDT"
KPTI,https://www.nasdaq.com/press-release/karyopharm-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21,"MAY 17, 2021 4:05PM EDT"
KRBP,https://www.nasdaq.com/press-release/kiromic-biopharma-inc.-announces-closing-of-public-offering-2021-07-02,"JUN 25, 2021 8:00AM EDT"
KRMD,https://www.nasdaq.com/press-release/koru-medical-systems-announces-2021-first-quarter-financial-results-2021-05-12,"JUL 12, 2021 7:00AM EDT"
KRON,https://www.nasdaq.com/press-release/kronos-bio-announces-participation-in-upcoming-investor-conferences-2021-05-26,"MAR 10, 2021 6:00PM EST"
KROS,https://www.nasdaq.com/press-release/keros-therapeutics-announces-preliminary-results-from-its-phase-2-clinical-trial,"JUL 13, 2021 4:05PM EDT"
KRTX,https://www.nasdaq.com/press-release/puretech-founded-entity-karuna-therapeutics-announces-results-from-phase-1b-trial,"JUN 17, 2021 8:00AM EDT"
KRYS,https://www.nasdaq.com/press-release/krystal-biotech-provides-update-on-the-clinical-trial-evaluating-topical-kb105-for,"JUN 29, 2021 7:00AM EDT"
KTRA,https://www.nasdaq.com/press-release/kintara-reports-topline-results-from-phase-2-clinical-trial-of-val-083-for-recurrent,"JUL 13, 2021 8:35AM EDT"
KURA,https://www.nasdaq.com/press-release/kura-oncology-announces-clinical-collaboration-to-evaluate-tipifarnib-in-combination,"JUL 8, 2021 8:00AM EDT"
KYMR,https://www.nasdaq.com/press-release/kymera-therapeutics-presents-new-preclinical-data-on-stat3-degraders-showing,"JUL 1, 2021 7:00AM EDT"
KZIA,https://www.nasdaq.com/press-release/kazia-provides-progress-update-on-paxalisib-and-evt801-clinical-programs-2021-06-30,"MAY 7, 2021 6:00AM EDT"
KZR,https://www.nasdaq.com/press-release/kezar-life-sciences-to-participate-in-the-william-blair-biotech-focus-conference-2021,"JUL 13, 2021 5:47PM EDT"
LABP,https://www.nasdaq.com/press-release/landos-biopharma-to-present-at-the-raymond-james-virtual-human-health-innovation,"JUL 7, 2021 8:30AM EDT"
LAKE,https://www.nasdaq.com/press-release/lakeland-industries-announces-new-%245.0-million-expansion-to-stock-repurchase-program,"JUL 14, 2021 9:00AM EDT"
LCI,https://www.nasdaq.com/press-release/lannett-launches-fluvastatin-sodium-er-tablets-2021-07-12,"JUL 7, 2021 2:16PM EDT"
LCTX,https://www.nasdaq.com/press-release/opregenr-data-update-to-be-featured-at-54th-annual-retina-society-meeting-in-podium,"JUN 28, 2021 4:32PM EDT"
LEGN,https://www.nasdaq.com/press-release/legend-biotech-announces-advancement-of-global-manufacturing-infrastructure-2021-06,"JUL 14, 2021 9:00AM EDT"
LEXX,https://www.nasdaq.com/press-release/lexaria-receives-patent-protection-in-japan-2021-07-13,"MAY 27, 2021 4:05PM EDT"
LEXXW,,"JUL 12, 2021 4:30PM EDT"
LFVN,https://www.nasdaq.com/press-release/lifevantage-announces-financial-results-for-the-third-quarter-of-fiscal-2021-2021-04,"JUL 7, 2021 8:00AM EDT"
LGND,https://www.nasdaq.com/press-release/genscript-biotech-and-ligand-pharmaceuticals-enter-into-global-omniabr-licensing,"JUN 30, 2021 7:46PM EDT"
LGVW,https://www.nasdaq.com/press-release/butterfly-network-a-global-leader-in-democratizing-medical-imaging-closes-business,"JUL 8, 2021 6:30AM EDT"
LH,https://www.nasdaq.com/press-release/labcorp-to-announce-second-quarter-financial-results-on-july-29-2021-2021-07-02,"JUN 16, 2021 7:30AM EDT"
LHCG,https://www.nasdaq.com/press-release/lhc-group-and-scp-health-partner-to-provide-advanced-clinical-care-in-the-home-2021,"JUL 7, 2021 7:00AM EDT"
LHDX,https://www.nasdaq.com/press-release/luciratm-health-hires-chief-revenue-officer-kevin-collins-2021-05-28,"MAY 11, 2021 8:00AM EDT"
LIFE,https://www.nasdaq.com/press-release/atyr-pharma-announces-last-patient-visit-in-phase-1b-2a-clinical-trial-of-atyr1923-in,"JUL 12, 2021 6:00PM EDT"
LIVN,https://www.nasdaq.com/press-release/livanova-to-host-conference-call-for-second-quarter-2021-results-2021-06-28,"MAY 26, 2021 7:00AM EDT"
LIXT,https://www.nasdaq.com/press-release/lixte-biotechnology-comments-on-outside-research-citing-lb-100s-pp2a-inhibition-as-a,"JUL 7, 2021 4:30PM EDT"
LIXTW,,"JUL 7, 2021 8:00AM EDT"
LJPC,https://www.nasdaq.com/press-release/la-jolla-pharmaceutical-company-announces-financial-results-for-the-three-months-0,"JUL 13, 2021 9:15AM EDT"
LLY,https://www.nasdaq.com/press-release/lilly-announces-acquisition-of-protomer-technologies-2021-07-14,"JUL 9, 2021 4:05PM EDT"
LMAT,https://www.nasdaq.com/press-release/lemaitre-announces-pricing-of-public-offering-of-common-stock-2021-07-13,"JUN 28, 2021 6:15AM EDT"
LMNL,https://www.nasdaq.com/press-release/liminal-biosciences-announces-closing-of-sale-of-plasma-derived-therapeutics,"JUL 6, 2021 6:30AM EDT"
LMNX,https://www.nasdaq.com/press-release/middlesex-water-set-to-join-sp-smallcap-600-2021-07-12,"JUL 12, 2021 8:00AM EDT"
LNSR,https://www.nasdaq.com/press-release/lensar-to-present-at-the-oppenheimer-medtech-tools-diagnostics-summit-2021-05-24,"JUN 10, 2021 6:00AM EDT"
LNTH,https://www.nasdaq.com/press-release/lantheus-holdings-to-host-second-quarter-2021-earnings-conference-call-and-webcast-on,"JUL 1, 2021 10:45AM EDT"
LOGC,https://www.nasdaq.com/press-release/logicbio-therapeutics-to-participate-in-william-blair-biotech-focus-conference-2021,"JUL 9, 2021 6:35AM EDT"
LPCN,https://www.nasdaq.com/press-release/lipocine-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021-07-06,"JUN 29, 2021 4:05PM EDT"
LPTX,https://www.nasdaq.com/press-release/leap-therapeutics-to-present-at-ladenburg-thalmann-2021-virtual-healthcare-conference,"JUN 2, 2021 8:00AM EDT"
LQDA,https://www.nasdaq.com/press-release/united-therapeutics-pursues-new-claims-for-trade-secret-misappropriation-against,"JUL 12, 2021 6:55AM EDT"
LRMR,https://www.nasdaq.com/press-release/larimar-therapeutics-to-present-at-the-william-blair-biotech-focus-conference-2021,"JUL 6, 2021 7:00AM EDT"
LTRN,,"JUL 12, 2021 9:44AM EDT"
LUMO,https://www.nasdaq.com/press-release/lumos-pharma-announces-oragrowth212-trial-of-lum-201-in-pghd-is-open-for-enrollment,"JUL 1, 2021 8:00AM EDT"
LUNA,https://www.nasdaq.com/press-release/luna-innovations-adds-more-bench-strength-2021-06-21,"MAY 26, 2021 8:00AM EDT"
LUNG,https://www.nasdaq.com/press-release/zephyrr-valve-treatment-provides-long-term-quality-of-life-and-lung-function,"JUN 24, 2021 4:42PM EDT"
LXRX,https://www.nasdaq.com/press-release/lexicon-pharmaceuticals-announces-symposium-at-the-american-diabetes-association-81st,"JUL 7, 2021 4:20PM EDT"
LYRA,https://www.nasdaq.com/press-release/lyra-therapeutics-to-present-at-upcoming-virtual-healthcare-conference-2021-07-12,"MAY 26, 2021 4:10PM EDT"
MACK,https://www.nasdaq.com/press-release/merrimack-reports-full-year-2020-financial-results-2021-03-10,"JUL 1, 2021 5:00PM EDT"
MASI,https://www.nasdaq.com/press-release/masimo-to-report-second-quarter-2021-financial-results-after-market-close-on-tuesday,"JUL 6, 2021 8:05AM EDT"
MBIO,https://www.nasdaq.com/press-release/mustang-bio-awarded-massachusetts-life-sciences-center-tax-incentive-2021-06-17,"JUL 9, 2021 8:00AM EDT"
MBOT,https://www.nasdaq.com/press-release/microbot-medical-secures-patent-allowance-in-china-third-global-jurisdiction-in-2021,"MAY 20, 2021 8:00AM EDT"
MBRX,https://www.nasdaq.com/press-release/moleculin-receives-approval-to-extend-dose-escalation-in-phase-1-2-european-clinical,"JUL 12, 2021 9:50AM EDT"
MCK,https://www.nasdaq.com/press-release/mckesson-corporation-announces-offer-to-purchase-up-to-%24500-million-aggregate,"JUL 1, 2021 4:05PM EDT"
MCRB,https://www.nasdaq.com/press-release/seres-therapeutics-nestle-health-science-announce-ser-109-co-commercialization,"JUN 28, 2021 8:30AM EDT"
MD,https://www.nasdaq.com/press-release/mednax-reports-first-quarter-results-2021-05-07,"JUL 14, 2021 8:30AM EDT"
MDGL,https://www.nasdaq.com/press-release/madrigal-pharmaceuticals-offers-patients-resmetirom-in-a-planned-open-label-active,"JUN 3, 2021 8:30AM EDT"
MDGS,https://www.nasdaq.com/press-release/medigus%3A-increases-holdings-in-gix-to-approximately-36.7-on-a-fully-diluted-basis,"JUN 22, 2021 8:00AM EDT"
MDGSW,,"JUL 7, 2021 2:07PM EDT"
MDNA,https://www.nasdaq.com/press-release/medicennas-il-2-superkine-platform-featured-in-peer-reviewed-publication,"JUN 24, 2021 7:00AM EDT"
MDT,https://www.nasdaq.com/press-release/a-culture-of-belonging-that-drives-innovation-2021-07-07,"JUL 8, 2021 4:01PM EDT"
MDVL,https://www.nasdaq.com/press-release/medavail-added-to-russell-2000r-and-3000r-indexes-2021-06-28,"JUL 9, 2021 4:05PM EDT"
MDXG,https://www.nasdaq.com/press-release/naacp-to-present-historic-spingarn-medal-to-regenerative-engineering-pioneer-cato-t.,"JUN 8, 2021 12:30PM EDT"
MEDP,https://www.nasdaq.com/press-release/medpace-holdings-inc.-to-report-second-quarter-2021-financial-results-on-july-26-2021,"JUN 30, 2021 4:15PM EDT"
MEDS,https://www.nasdaq.com/press-release/trxade-health-to-report-second-quarter-2021-financial-results-on-monday-july-26th-at,"JUL 8, 2021 6:50AM EDT"
MEIP,https://www.nasdaq.com/press-release/mei-pharma-appoints-tina-c.-beamon-j.d.-as-chief-compliance-officer-2021-07-07,"MAY 25, 2021 8:00AM EDT"
MESO,https://www.nasdaq.com/press-release/mesoblast-provides-update-on-program-for-chronic-low-back-pain-due-to-degenerative,"JUL 7, 2021 8:00AM EDT"
MGLN,https://www.nasdaq.com/press-release/magellan-rx-management-and-heuro-health-collaborate-to-offer-live-behavioral-health,"JUN 18, 2021 7:30AM EDT"
MGNX,https://www.nasdaq.com/press-release/macrogenics-and-zai-lab-enter-into-broad-strategic-collaboration-to-develop-and,"JUN 28, 2021 8:45AM EDT"
MGTA,https://www.nasdaq.com/press-release/former-magenta-therapeutics-and-foundation-medicine-cfo-jason-ryan-to-join-sema4,"MAR 12, 2021 9:04AM EST"
MGTX,https://www.nasdaq.com/press-release/meiragtx-reports-first-quarter-2021-financial-and-operational-results-2021-05-11,"JUL 12, 2021 7:30AM EDT"
MIRM,https://www.nasdaq.com/press-release/mirum-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12,"JUL 13, 2021 4:15PM EDT"
MIST,https://www.nasdaq.com/press-release/milestone-pharmaceuticals-to-present-at-the-jefferies-virtual-healthcare-conference,"JUN 10, 2021 8:30AM EDT"
MITO,https://www.nasdaq.com/press-release/stealth-biotherapeutics-joins-the-rare-disease-company-coalition-2021-07-07,"MAY 25, 2021 4:17PM EDT"
MLND,,"JUL 7, 2021 7:00AM EDT"
MLSS,https://www.nasdaq.com/press-release/milestone-scientific-commences-sales-of-compuflor-cathchecktm-disposables-within-the,"JUN 18, 2021 9:20PM EDT"
MMM,https://www.nasdaq.com/press-release/3m-announces-upcoming-investor-event-2021-07-13,"JUN 7, 2021 8:30AM EDT"
MMSI,https://www.nasdaq.com/press-release/merit-medical-systems-to-announce-second-quarter-results-on-july-29-2021-2021-07-09,"JUL 14, 2021 7:00AM EDT"
MNKD,https://www.nasdaq.com/press-release/policy-change-allows-approval-for-medicare-patients-living-with-diabetes-to-use-both,"JUL 9, 2021 8:15AM EDT"
MNOV,https://www.nasdaq.com/press-release/medicinova-receives-notice-of-allowance-for-new-patent-covering-mn-166-ibudilast-1,"MAY 26, 2021 8:00AM EDT"
MNPR,https://www.nasdaq.com/press-release/monopar-appoints-octavio-costa-md-as-chief-medical-officer-2021-07-12,"JUL 12, 2021 8:15AM EDT"
MOH,https://www.nasdaq.com/press-release/molina-healthcare-announces-second-quarter-2021-earnings-release-and-conference-call,"JUL 8, 2021 7:30AM EDT"
MOR,https://www.nasdaq.com/press-release/morphosys-announces-expiration-of-the-hart-scott-rodino-waiting-period-for,"JUL 12, 2021 7:00AM EDT"
MORF,https://www.nasdaq.com/press-release/morphic-reports-new-data-from-positive-phase-1-study-of-morf-057-oral-integrin,"MAY 17, 2021 6:45AM EDT"
MOTS,https://www.nasdaq.com/press-release/motus-gi-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021-06-29,"JUN 24, 2021 8:05AM EDT"
MREO,https://www.nasdaq.com/press-release/mereo-biopharma-announces-positive-desmosine-biomarker-data-from-an-interim-analysis,"JUL 12, 2021 8:30AM EDT"
MRK,https://www.nasdaq.com/press-release/merck-announces-presentation-of-new-data-from-broad-hiv-program-at-ias-2021-2021-07,"JUL 8, 2021 4:15PM EDT"
MRKR,https://www.nasdaq.com/press-release/marker-therapeutics-announces-completion-of-safety-lead-in-portion-of-phase-2-study,"JUL 13, 2021 4:01PM EDT"
MRNA,https://www.nasdaq.com/press-release/moderna-announces-supply-agreement-with-argentina-for-20-million-doses-of-its-covid,"JUN 2, 2021 8:04AM EDT"
MRNS,https://www.nasdaq.com/press-release/marinus-pharmaceuticals-further-strengthens-board-of-directors-with-appointment-of,"JUL 8, 2021 6:00AM EDT"
MRSN,https://www.nasdaq.com/press-release/mersana-therapeutics-to-present-at-jefferies-virtual-healthcare-conference-2021-05-26,"MAR 16, 2021 8:18PM EDT"
MRTX,https://www.nasdaq.com/press-release/mirati-therapeutics-adagrasib-receives-breakthrough-therapy-designation-from-u.s.,"JUL 2, 2021 4:01PM EDT"
MRUS,https://www.nasdaq.com/press-release/merus-to-participate-in-william-blairs-biotech-focus-conference-2021-2021-07-07,"MAR 23, 2021 5:25PM EDT"
MRVI,https://www.nasdaq.com/press-release/maravai-lifesciences-announces-june-2021-investor-conference-schedule-2021-05-26,"JUL 2, 2021 11:00AM EDT"
MSA,https://www.nasdaq.com/press-release/msa-safety-completes-acquisition-of-bacharach-inc.-a-leader-in-heating-ventilation,"JUL 1, 2021 4:10PM EDT"
MTCR,https://www.nasdaq.com/press-release/metacrine-to-present-new-preclinical-data-in-inflammatory-bowel-disease-ibd-at,"JUN 15, 2021 9:00AM EDT"
MTEM,https://www.nasdaq.com/press-release/molecular-templates-inc.-announces-dosing-of-first-subject-in-phase-1-study-of-mt,"JUL 12, 2021 10:30AM EDT"
MTNB,https://www.nasdaq.com/press-release/matinas-biopharma-to-hold-virtual-rd-day-on-june-17-2021-2021-05-20,"JUN 30, 2021 7:00AM EDT"
MTP,https://www.nasdaq.com/press-release/midatech-pharma-plc-announces-appointment-of-chief-scientific-officer-2021-07-12,"JUL 6, 2021 8:30AM EDT"
MYGN,https://www.nasdaq.com/press-release/myriad-genetics-completes-sale-of-myriad-rbm-to-iqvias-q2-solutions-2021-07-01,"JUL 13, 2021 9:05AM EDT"
MYO,https://www.nasdaq.com/press-release/myomo-inc.-stock-added-to-russell-microcapr-index-2021-06-28,"JUL 8, 2021 7:30AM EDT"
MYOV,https://www.nasdaq.com/press-release/myovant-sciences-to-host-first-fiscal-quarter-2021-earnings-conference-call-at-8%3A30-a,"JUL 13, 2021 8:00AM EDT"
NAOV,https://www.nasdaq.com/press-release/nanovibronix-provides-business-update-2021-06-03,"JUL 12, 2021 7:00AM EDT"
NARI,https://www.nasdaq.com/press-release/inari-medical-appoints-outset-medical-executive-rebecca-chambers-to-board-of,"JUL 7, 2021 7:00AM EDT"
NATR,https://www.nasdaq.com/press-release/natures-sunshine-appoints-tariq-h.-hassan-to-board-of-directors-2021-07-07,"JUN 23, 2021 11:11AM EDT"
NAVB,https://www.nasdaq.com/press-release/macrophage-therapeutics-inc.-wins-delaware-case-against-michael-goldberg-for-breach,"JUL 12, 2021 4:10PM EDT"
NBIX,https://www.nasdaq.com/press-release/neurocrine-biosciences-to-participate-at-the-william-blair-biotech-focus-conference-0,"JUN 22, 2021 8:00AM EDT"
NBRV,https://www.nasdaq.com/press-release/nabriva-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5,"JUL 6, 2021 4:05PM EDT"
NBSE,https://www.nasdaq.com/press-release/neubase-therapeutics-demonstrates-functional-rescue-in-myotonic-dystrophy-type-1,"MAY 6, 2021 1:30PM EDT"
NBTX,https://www.nasdaq.com/press-release/nanobiotix-announces-initiation-of-new-clinical-study-evaluating-nbtxr3-in-lung,"JUL 2, 2021 1:00AM EDT"
NBY,https://www.nasdaq.com/press-release/novabay-pharmaceuticals-to-participate-in-two-july-investment-conferences-2021-07-08,"JUL 9, 2021 3:17PM EDT"
NCNA,https://www.nasdaq.com/press-release/nucana-to-present-at-the-jefferies-virtual-healthcare-conference-2021-05-25,"JUL 2, 2021 5:42PM EDT"
NDRA,https://www.nasdaq.com/press-release/endra-life-sciences-strengthens-taeusr-system-intellectual-property-protection-with,"JUN 29, 2021 8:00AM EDT"
NDRAW,,"JUL 13, 2021 9:00AM EDT"
NEO,https://www.nasdaq.com/press-release/neogenomics-completes-inivata-acquisition-combining-best-in-class-liquid-biopsy,"JUN 22, 2021 8:00AM EDT"
NEOG,https://www.nasdaq.com/press-release/neogen-gencove-extend-animal-genomics-partnership-2021-06-28,"MAY 14, 2021 8:30AM EDT"
NEOS,https://www.nasdaq.com/press-release/glass-lewis-a-leading-independent-proxy-advisory-firm-recommends-neos-therapeutics,"JUL 12, 2021 7:00AM EDT"
NEPH,https://www.nasdaq.com/press-release/nephros-announces-acquisition-of-genarraytion-inc.-2021-07-12,"JUL 1, 2021 7:00AM EDT"
NEPT,https://www.nasdaq.com/press-release/neptune-to-report-fiscal-fourth-quarter-and-full-year-2021-financial-results-on-july,"JUL 13, 2021 6:00AM EDT"
NERV,https://www.nasdaq.com/press-release/minerva-neurosciences-to-present-at-jmp-securities-life-sciences-conference-2021-06,"MAY 18, 2021 4:05PM EDT"
NFH,https://www.nasdaq.com/press-release/new-frontier-health-corporation-receives-nyse-notice-regarding-late-form-20-f-filing,"JUL 1, 2021 5:00PM EDT"
NGM,https://www.nasdaq.com/press-release/ngm-bio-announces-initiation-of-phase-1-2-clinical-study-of-ngm707-for-the-treatment,"JUN 14, 2021 8:30AM EDT"
NHC,https://www.nasdaq.com/press-release/nhc-acquires-outstanding-interest-in-caris-healthcare-2021-06-18,"JUN 30, 2021 7:35AM EDT"
NK,,"JUN 17, 2021 7:00AM EDT"
NKTR,https://www.nasdaq.com/press-release/nektar-therapeutics-to-participate-in-fireside-chat-at-the-goldman-sachs-42nd-annual,"JUL 6, 2021 4:01PM EDT"
NKTX,https://www.nasdaq.com/press-release/nkarta-establishes-new-combined-nk-cell-therapy-manufacturing-facility-company,"JUL 1, 2021 4:05PM EDT"
NLSP,https://www.nasdaq.com/press-release/nls-pharmaceutics-to-present-at-the-access-to-giving-virtual-investor-conference-on,"JUN 30, 2021 7:00AM EDT"
NLSPW,,"JUN 8, 2021 5:50AM EDT"
NLTX,https://www.nasdaq.com/press-release/neoleukin-therapeutics-to-participate-in-jefferies-virtual-healthcare-conference-2021,"JUN 28, 2021 8:00AM EDT"
NMRD,https://www.nasdaq.com/press-release/nemaura-medical-to-present-at-the-access-to-giving-virtual-investor-conference-on,"MAR 2, 2021 8:05AM EST"
NMTR,https://www.nasdaq.com/press-release/9-meters-biopharma-inc.-to-present-at-the-william-blair-biotech-focus-conference-2021,"JUL 13, 2021 4:05PM EDT"
NNOX,https://www.nasdaq.com/press-release/nanox-signs-msaas-agreement-for-the-deployment-of-1000-nanox-systems-in-nigeria-2021,"JUL 12, 2021 8:00AM EDT"
NNVC,https://www.nasdaq.com/press-release/nanoviricides-has-filed-quarterly-report-for-period-ending-march-31-2021-has,"JUL 12, 2021 8:00AM EDT"
NOVN,https://www.nasdaq.com/press-release/novan-announces-inclusion-in-russell-microcapr-index-2021-06-24,"JUN 24, 2021 8:00AM EDT"
NRBO,https://www.nasdaq.com/press-release/neurobo-pharmaceuticals-shareholders-elect-hyung-heon-kim-and-andrew-i.-koven-to,"JUL 2, 2021 7:30AM EDT"
NRC,https://www.nasdaq.com/press-release/nrc-healths-chief-security-and-privacy-officer-recognized-as-one-of-the-top-100-cisos,"JUL 6, 2021 7:00AM EDT"
NRIX,https://www.nasdaq.com/press-release/nurix-therapeutics-reports-second-quarter-fiscal-2021-financial-results-and-provides,"JUN 28, 2021 8:00AM EDT"
NSPR,https://www.nasdaq.com/press-release/inspiremd-to-present-at-the-ld-micro-virtual-invitational-conference-on-june-9-2021,"JUN 22, 2021 8:40AM EDT"
NSTG,https://www.nasdaq.com/press-release/nanostring-to-release-second-quarter-2021-operating-results-and-host-conference-call,"JUN 30, 2021 8:00AM EDT"
NTEC,https://www.nasdaq.com/press-release/intec-pharma-announces-filing-of-2020-annual-report-on-form-10-k-2021-03-16,"JUL 1, 2021 1:00AM EDT"
NTLA,https://www.nasdaq.com/press-release/intellia-therapeutics-announces-closing-of-%24690-million-public-offering-of-common,"JUN 7, 2021 8:30AM EDT"
NTN,https://www.nasdaq.com/press-release/ntn-buzztime-announces-proposed-reverse-stock-split-ratio-and-anticipated-closing-of,"JUN 30, 2021 7:15AM EDT"
NTRA,https://www.nasdaq.com/press-release/new-results-from-the-landmark-prospective-circulate-trial-expand-clinical-utility-of,"JUN 17, 2021 4:05PM EDT"
NTUS,https://www.nasdaq.com/press-release/natus-medical-to-hold-2021-second-quarter-financial-results-conference-call-on-august,"JUN 15, 2021 7:30AM EDT"
NURO,https://www.nasdaq.com/press-release/neurometrix-reports-that-quellr-technology-is-to-be-evaluated-for-neuromyelitis,"JUL 7, 2021 8:05AM EDT"
NUS,https://www.nasdaq.com/press-release/grov-technologies-signs-definitive-agreement-with-superior-farms-to-bring,"JUL 7, 2021 8:00AM EDT"
NUVA,https://www.nasdaq.com/press-release/nuvasive-receives-latest-ce-mark-approval-for-pulse-platform-and-starts-global,"MAY 5, 2021 4:05PM EDT"
NVAX,https://www.nasdaq.com/press-release/novavax-to-host-conference-call-to-discuss-second-quarter-financial-results-and,"JUL 8, 2021 4:30PM EDT"
NVCN,https://www.nasdaq.com/press-release/neovasc-announces-new-appointments-in-regulatory-and-clinical-leadership-2021-07-13,"MAR 4, 2021 2:26PM EST"
NVCR,https://www.nasdaq.com/press-release/novocure-to-report-second-quarter-2021-financial-results-2021-07-08,"JUL 1, 2021 6:00AM EDT"
NVIV,https://www.nasdaq.com/press-release/invivo-therapeutics-announces-fda-acceptance-of-preclinical-module-in-support-of,"MAY 6, 2021 4:40PM EDT"
NVO,https://www.nasdaq.com/press-release/prothena-and-novo-nordisk-announce-acquisition-agreement-for-prothenas-attr,"FEB 10, 2021 4:05PM EST"
NVRO,https://www.nasdaq.com/press-release/nevro-to-report-second-quarter-2021-financial-results-2021-07-07,"APR 1, 2021 8:30AM EDT"
NVS,https://www.nasdaq.com/press-release/novartis-and-hewlett-packard-enterprise-join-forces-to-advance-novartis-global-health,"JUN 1, 2021 7:00AM EDT"
NVST,https://www.nasdaq.com/press-release/envista-schedules-second-quarter-2021-earnings-call-2021-07-12,"JUN 14, 2021 9:30AM EDT"
NVTA,https://www.nasdaq.com/press-release/opko-health-appoints-katherine-stueland-as-president-and-ceo-of-genedx-2021-06-22,"JUL 1, 2021 4:01PM EDT"
NXTC,https://www.nasdaq.com/press-release/nextcure-initiates-phase-1-2-clinical-trial-of-nc762-for-solid-tumors-2021-07-06,"JUL 8, 2021 11:20AM EDT"
NYMX,https://www.nasdaq.com/press-release/nymox-announces-date-for-fexapotide-filing-2021-05-06,"JUL 2, 2021 5:15PM EDT"
OBLN,,"JUL 13, 2021 8:00AM EDT"
OBSV,https://www.nasdaq.com/press-release/obseva-to-present-ebopiprant-obe022-data-at-the-society-for-reproductive,"JUL 8, 2021 11:20AM EDT"
OCDX,https://www.nasdaq.com/press-release/ortho-clinical-diagnostics-quantitative-covid-19-igg-antibody-test-first-to-receive,"MAY 27, 2021 4:05PM EDT"
OCGN,https://www.nasdaq.com/press-release/ocugens-covid-19-vaccine-co-development-partner-bharat-biotech-shares-phase-3-results,"JUL 13, 2021 8:00AM EDT"
OCUL,https://www.nasdaq.com/press-release/ocular-therapeutixtm-and-mosaic-biosciences-enter-into-strategic-discovery,"JUN 3, 2021 11:18AM EDT"
OCUP,https://www.nasdaq.com/press-release/ocuphire-selected-to-present-at-multiple-ophthalmic-conferences-in-july-2021-07-13,"JUL 1, 2021 8:30AM EDT"
OCX,https://www.nasdaq.com/press-release/oncocyte-celebrates-women-thoracic-surgeons-in-shesmysurgeon-campaign-2021-06-22,"JUL 12, 2021 4:05PM EDT"
ODT,https://www.nasdaq.com/press-release/odonate-therapeutics-announces-financial-results-for-the-three-months-ended-march-0,"MAY 26, 2021 4:05PM EDT"
OFIX,https://www.nasdaq.com/press-release/publication-of-data-shows-high-fusion-rate-in-patients-treated-with-pemf-therapy,"MAY 3, 2021 8:00AM EDT"
OGEN,https://www.nasdaq.com/press-release/oragenics-announces-adjournment-of-annual-meeting-of-shareholders-due-to-lack-of,"JUL 8, 2021 4:06PM EDT"
OGI,https://www.nasdaq.com/press-release/organigram-reports-third-quarter-fiscal-2021-results-2021-07-13,"JUN 10, 2021 5:05PM EDT"
OLMA,https://www.nasdaq.com/press-release/olema-oncology-to-participate-at-the-jefferies-2021-virtual-healthcare-conference,"JUN 4, 2021 11:00AM EDT"
OM,https://www.nasdaq.com/press-release/outset-medical-announces-departure-of-cfo-and-appointment-of-nabeel-ahmed-as-interim,"JUL 1, 2021 1:00AM EDT"
OMER,https://www.nasdaq.com/press-release/omeros-narsoplimab-pivotal-trial-data-shared-in-oral-presentation-at-2021-annual,"JUN 30, 2021 4:00PM EDT"
OMI,https://www.nasdaq.com/press-release/owens-minor-pursues-sustainable-solutions-for-healthcare-through-electric-truck-pilot,"MAY 25, 2021 4:01PM EDT"
ONCR,https://www.nasdaq.com/press-release/oncorus-appoints-eric-rubin-m.d.-to-its-board-of-directors-2021-06-17,"JUL 8, 2021 9:00AM EDT"
ONCS,https://www.nasdaq.com/press-release/oncosec-enters-into-a-collaboration-agreement-with-merck-for-a-pivotal-global-phase-3,"JUN 14, 2021 6:30AM EDT"
ONCT,https://www.nasdaq.com/press-release/oncternal-therapeutics-appoints-pablo-urbaneja-as-sr.-vice-president-corporate,"JUL 7, 2021 4:30PM EDT"
ONCY,https://www.nasdaq.com/press-release/oncolytics-biotechr-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021,"JUL 9, 2021 6:10PM EDT"
ONEM,https://www.nasdaq.com/press-release/one-medical-appoints-scott-c.-taylor-to-board-of-directors-2021-06-08,"JUN 25, 2021 7:00AM EDT"
ONTX,https://www.nasdaq.com/press-release/onconova-therapeutics-provides-an-update-on-the-phase-1-2a-trial-of-rigosertib,"MAY 10, 2021 4:21PM EDT"
ONTXW,,"JUL 1, 2021 8:00AM EDT"
ONVO,https://www.nasdaq.com/press-release/organovo-announces-participation-at-the-h.c.-wainwright-global-life-sciences,"JUN 2, 2021 6:50AM EDT"
OPCH,https://www.nasdaq.com/press-release/option-care-health-to-announce-second-quarter-2021-financial-results-and-host,"JUL 12, 2021 4:30PM EDT"
OPGN,,"JUN 1, 2021 2:54PM EDT"
OPK,https://www.nasdaq.com/press-release/opko-health-licenses-oligonucleotide-therapeutics-platform-to-camp4-therapeutics-2021,"JUN 9, 2021 8:00AM EDT"
OPNT,https://www.nasdaq.com/press-release/opiant-pharmaceuticals-announces-appointment-of-matthew-ruth-as-chief-commercial,"JUN 17, 2021 8:00AM EDT"
OPTN,https://www.nasdaq.com/press-release/optinose-technology-inventor-per-djupesland-named-winner-of-european-inventor-award,"JUN 22, 2021 8:30AM EDT"
ORGO,https://www.nasdaq.com/press-release/organogenesis-holdings-inc.-to-report-second-quarter-of-fiscal-year-2021-financial,"JUL 1, 2021 6:00AM EDT"
ORGS,https://www.nasdaq.com/press-release/orgenesis-achieves-multiple-ranpirnase-development-milestones-2021-07-06,"JUN 4, 2021 8:00AM EDT"
ORIC,https://www.nasdaq.com/press-release/oric-pharmaceuticals-announces-fda-clearance-of-ind-application-for-oric-533-a-highly,"JUN 28, 2021 6:07PM EDT"
ORMP,https://www.nasdaq.com/press-release/oramed-pharmaceuticals-to-join-russell-2000r-and-russell-3000r-indexes-2021-06-22,"JUL 6, 2021 9:00AM EDT"
ORPH,https://www.nasdaq.com/press-release/cytrx-comments-on-orphazymes-promising-24-month-interim-trial-results-of-arimoclomol,"MAY 13, 2021 8:15AM EDT"
ORTX,https://www.nasdaq.com/press-release/orchard-therapeutics-and-pharming-group-announce-collaboration-to-develop-and,"JUL 6, 2021 4:33PM EDT"
OSH,https://www.nasdaq.com/press-release/oak-street-health-announces-plans-to-enter-20th-state-arizona-centers-to-open-in-2022,"JUN 2, 2021 7:00AM EDT"
OSMT,https://www.nasdaq.com/press-release/osmotica-subsidiary-rvl-pharmaceuticals-focused-on-eye-care-and-ocular-aesthetics,"MAY 25, 2021 4:30PM EDT"
OSUR,https://www.nasdaq.com/press-release/orasure-technologies-to-present-at-the-raymond-james-2021-human-health-and-innovation,"JUN 30, 2021 7:30AM EDT"
OTIC,https://www.nasdaq.com/press-release/otonomy-initiates-expansion-of-phase-1-2-clinical-trial-for-oto-413-in-hearing-loss,"JUL 12, 2021 8:30AM EDT"
OTLK,https://www.nasdaq.com/press-release/outlook-therapeutics-appoints-c.-russell-trenary-iii-as-president-and-chief-executive,"JUN 10, 2021 7:00AM EDT"
OTLKW,,"JUL 12, 2021 7:00AM EDT"
OTRK,https://www.nasdaq.com/press-release/landmark-behavioral-health-study-presented-at-ahip-event-2021-07-07,"JUL 9, 2021 7:00AM EDT"
OTRKP,https://www.nasdaq.com/press-release/ontrak-declares-quarterly-dividend-on-9.50-non-convertible-series-a-preferred-stock-0,"JUN 29, 2021 8:00AM EDT"
OVID,https://www.nasdaq.com/press-release/ovid-therapeutics-strengthens-board-leadership-team-to-focus-efforts-on-expanding-its,"JUL 12, 2021 7:00AM EDT"
OXFD,https://www.nasdaq.com/press-release/oxford-immunotec-submits-emergency-use-authorization-request-to-the-fda-and-ce-marks,"JUN 22, 2021 9:01AM EDT"
OYST,https://www.nasdaq.com/press-release/oyster-point-pharma-announces-preclinical-data-highlighting-potent-activity-of-oc-01,"JUL 8, 2021 7:10AM EDT"
PAHC,https://www.nasdaq.com/press-release/phibro-animal-health-corporation-reports-third-quarter-and-year-to-date-results-2021,"JUN 16, 2021 7:30AM EDT"
PANA,https://www.nasdaq.com/press-release/nuvation-bio-closes-transaction-with-panacea-debuts-as-publicly-traded-oncology,"JUN 2, 2021 8:00AM EDT"
PAND,https://www.nasdaq.com/press-release/merck-completes-acquisition-of-pandion-therapeutics-2021-04-01,"JUN 24, 2021 8:00AM EDT"
PASG,https://www.nasdaq.com/press-release/derrell-d.-porter-m.d.-elected-to-board-of-directors-of-passage-bio-2021-06-01,"JUL 12, 2021 8:00AM EDT"
PAVM,https://www.nasdaq.com/press-release/tim-baxter-former-ceo-of-samsung-electronics-north-america-and-global-technology,"JUN 30, 2021 4:27PM EDT"
PAVMW,,"JUL 8, 2021 4:15PM EDT"
PAVMZ,,"JUL 13, 2021 9:15AM EDT"
PBH,https://www.nasdaq.com/press-release/prestige-consumer-healthcare-completes-acquisition-of-theratears-announces-first,"MAY 11, 2021 4:35PM EDT"
PBLA,https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0,"JUL 12, 2021 8:00AM EDT"
PBYI,https://www.nasdaq.com/press-release/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-rule-5635c4-2021-07,"JUL 12, 2021 9:15AM EDT"
PCRX,https://www.nasdaq.com/press-release/pacira-biosciences-reports-record-revenue-of-%24135.6-million-for-the-second-quarter-of,"JUL 12, 2021 11:55AM EDT"
PCSA,https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0,"JUL 14, 2021 7:30AM EDT"
PCVX,https://www.nasdaq.com/press-release/vaxcyte-to-present-at-the-jefferies-virtual-healthcare-conference-2021-05-27,"JUL 9, 2021 8:00AM EDT"
PDCO,https://www.nasdaq.com/press-release/patterson-announces-dental-leadership-changes-2021-07-13,"JUL 2, 2021 4:30PM EDT"
PDEX,https://www.nasdaq.com/press-release/pro-dex-inc.-discusses-record-third-quarter-sales-and-aggressive-growth-strategy-with,"JUL 2, 2021 9:00AM EDT"
PDSB,https://www.nasdaq.com/press-release/pds-biotechnology-joins-russell-microcapr-index-2021-07-01,"JUN 24, 2021 7:05AM EDT"
PEN,https://www.nasdaq.com/press-release/penumbra-inc.-schedules-second-quarter-2021-earnings-release-and-conference-call-for,"JUN 18, 2021 12:24PM EDT"
PETQ,https://www.nasdaq.com/press-release/petiq-inc.-to-participate-in-two-upcoming-virtual-investor-conferences-2021-05-26,"JUL 13, 2021 3:30AM EDT"
PETS,https://www.nasdaq.com/press-release/petmed-express-inc.-d-b-a-1-800-petmeds-announces-its-fourth-quarter-and-fiscal-0,"JUN 29, 2021 4:23PM EDT"
PFE,https://www.nasdaq.com/press-release/collaboration-between-abbvie-biogen-and-pfizer-creates-worlds-largest-browsable-0,"MAY 13, 2021 7:00AM EDT"
PGEN,https://www.nasdaq.com/press-release/precigen-actobio-announces-positive-topline-results-from-phase-1b-2a-study-of-ag019,"JUL 12, 2021 4:10PM EDT"
PGNY,https://www.nasdaq.com/press-release/progyny-inc.-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference,"JUL 13, 2021 11:00AM EDT"
PHAR,https://www.nasdaq.com/press-release/orchard-therapeutics-and-pharming-group-announce-collaboration-to-develop-and,"JUN 28, 2021 3:21PM EDT"
PHAS,https://www.nasdaq.com/press-release/phasebio-pharmaceuticals-to-present-at-the-william-blair-biotech-focus-conference,"JUN 2, 2021 8:15AM EDT"
PHAT,https://www.nasdaq.com/press-release/phathom-pharmaceuticals-to-present-at-the-jefferies-virtual-healthcare-conference,"JUN 30, 2021 11:58PM EDT"
PHG,https://www.nasdaq.com/press-release/philips-and-cognizant-collaborate-to-introduce-digital-health-solutions-to-providers,"JUL 7, 2021 4:15PM EDT"
PHGE,https://www.nasdaq.com/press-release/biomx-presents-preclinical-results-with-bx005-for-atopic-dermatitis-at-the,"JUL 13, 2021 7:00AM EDT"
PHIO,https://www.nasdaq.com/press-release/phio-pharmaceuticals-scheduled-to-participate-in-a-fireside-chat-with-h.c.-wainwright,"JUL 7, 2021 8:00AM EDT"
PHIOW,,"JUN 7, 2021 1:30PM EDT"
PHVS,https://www.nasdaq.com/press-release/pharvaris-presents-clinical-data-on-oral-pha121-supporting-the-prophylactic-treatment,"JUL 13, 2021 7:30AM EDT"
PIRS,https://www.nasdaq.com/press-release/pieris-pharmaceuticals-announces-inhaled-ctgf-inhibitor-prs-220-for-idiopathic,"JUN 25, 2021 7:05AM EDT"
PLRX,https://www.nasdaq.com/press-release/pliant-therapeutics-provides-corporate-update-and-reports-first-quarter-2021,"JUN 9, 2021 7:05AM EDT"
PLSE,https://www.nasdaq.com/press-release/pulse-biosciences-announces-%2450-million-private-placement-2021-07-01,"JUL 14, 2021 7:30AM EDT"
PLX,https://www.nasdaq.com/press-release/protalix-biotherapeutics-and-chiesi-global-rare-diseases-provide-update-regarding,"JUN 15, 2021 8:00AM EDT"
PLXP,https://www.nasdaq.com/press-release/plx-pharma-inc.s-vazalore-to-launch-in-over-4500-walmart-stores-nationwide-in-august,"JUN 2, 2021 9:00AM EDT"
PMD,https://www.nasdaq.com/press-release/montana-advisors-writes-open-letter-to-psychemedics-2021-06-01,"JUN 29, 2021 6:50AM EDT"
PMVP,https://www.nasdaq.com/press-release/pmv-pharmaceuticals-announces-participation-at-the-bank-of-america-securities-2021,"JUN 28, 2021 7:00AM EDT"
PNTG,https://www.nasdaq.com/press-release/the-pennant-group-acquires-california-hospice-provider-2021-06-17,"MAY 19, 2021 9:00AM EDT"
POAI,https://www.nasdaq.com/press-release/predictive-oncology-inc.s-subsidiaries-soluble-biotech-inc.-and-tumorgenesis-inc.-are,"JUN 7, 2021 9:00AM EDT"
PODD,https://www.nasdaq.com/press-release/insulet-to-announce-second-quarter-2021-financial-results-on-august-5-2021-2021-07-01,"JUN 2, 2021 7:00AM EDT"
PPBT,https://www.nasdaq.com/press-release/purple-biotech-presents-new-clinical-data-from-nt219-at-the-2021-asco-annual-meeting,"JUN 23, 2021 4:01PM EDT"
PPD,,"JUN 24, 2021 4:05PM EDT"
PRAH,https://www.nasdaq.com/press-release/dt-midstream-set-to-join-sp-midcap-400-2021-06-28,"MAY 26, 2021 4:05PM EDT"
PRAX,https://www.nasdaq.com/press-release/praxis-precision-medicines-to-present-at-upcoming-investor-conferences-2021-07-06,"JUN 7, 2021 12:45PM EDT"
PRFX,https://www.nasdaq.com/press-release/painreform-provides-business-update-for-the-first-quarter-of-2021-2021-05-13,"JUN 28, 2021 7:00AM EDT"
PRGO,https://www.nasdaq.com/press-release/perrigo-completes-divestiture-of-generic-rx-business-for-%241.55-billion-2021-07-06,"MAY 11, 2021 7:23AM EDT"
PRLD,https://www.nasdaq.com/press-release/prelude-therapeutics-announces-participation-at-two-upcoming-virtual-investor,"MAY 27, 2021 8:00AM EDT"
PROF,https://www.nasdaq.com/press-release/profound-medical-to-participate-in-june-investor-conferences-2021-05-25,"JUN 28, 2021 7:00AM EDT"
PROG,https://www.nasdaq.com/press-release/progenity-announces-appointment-of-surbhi-sarna-to-its-board-of-directors-2021-06-30,"JUL 8, 2021 6:30AM EDT"
PRPH,https://www.nasdaq.com/press-release/prophase-labs-to-present-at-the-access-to-giving-virtual-investor-conference-on-july,"JUN 26, 2021 10:42AM EDT"
PRQR,https://www.nasdaq.com/press-release/proqr-to-present-at-upcoming-jmp-securities-life-sciences-conference-2021-06-10,"JUN 21, 2021 4:10PM EDT"
PRTA,https://www.nasdaq.com/press-release/prothena-and-novo-nordisk-announce-acquisition-agreement-for-prothenas-attr,"JUL 13, 2021 7:30AM EDT"
PRTC,https://www.nasdaq.com/press-release/puretech-founded-entity-vor-biopharma-announces-collaboration-with-janssen-to-develop,"JUL 7, 2021 7:30AM EDT"
PRTK,https://www.nasdaq.com/press-release/paratek-pharmaceuticals-announces-first-barda-project-bioshield-procurement-of,"JUL 13, 2021 4:08PM EDT"
PRVB,https://www.nasdaq.com/press-release/teplizumab-awarded-innovation-passport-in-the-united-kingdom-uk-for-the-delay-of,"JUL 12, 2021 8:30AM EDT"
PSNL,https://www.nasdaq.com/press-release/personalis-announces-next-level-biomarkers-symposium-2021-06-22,"JUL 12, 2021 8:00AM EDT"
PSTI,https://www.nasdaq.com/press-release/pluristem-brings-ards-associated-with-covid-19-phase-ii-studies-to-clinical-readout,"MAY 27, 2021 8:27AM EDT"
PSTV,https://www.nasdaq.com/press-release/plus-therapeutics-announces-dsmb-approval-to-proceed-into-eighth-cohort-in-respecttm,"JUL 14, 2021 8:00AM EDT"
PSTX,https://www.nasdaq.com/press-release/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders-2021-06-02,"JUL 8, 2021 8:00AM EDT"
PTCT,https://www.nasdaq.com/press-release/results-add-to-body-of-evidence-confirming-emflazars-benefit-over-prednisone-2021-06,"JUL 8, 2021 1:38PM EDT"
PTE,https://www.nasdaq.com/press-release/polarityte-receives-notice-of-allowance-for-chinese-patent-2021-07-12,"JUL 14, 2021 8:00AM EDT"
PTGX,https://www.nasdaq.com/press-release/protagonist-therapeutics-reports-granting-of-inducement-award-2021-06-30,"JUL 9, 2021 2:10PM EDT"
PTN,https://www.nasdaq.com/press-release/palatin-announces-adjournment-of-annual-meeting-of-stockholders-2021-07-08,"MAY 24, 2021 4:15PM EDT"
PTPI,https://www.nasdaq.com/press-release/petros-pharmaceuticals-completes-pilot-label-comprehension-study-to-initiate-process,"JUL 9, 2021 10:12AM EDT"
PULM,https://www.nasdaq.com/press-release/pulmatrix-reports-first-quarter-2021-financial-results-and-provides-business-update,"JUL 9, 2021 7:30AM EDT"
PYPD,https://www.nasdaq.com/press-release/polypid-strengthens-executive-team-appointing-dr.-anthony-senagore-as-senior-medical,"JUL 12, 2021 8:00AM EDT"
QDEL,https://www.nasdaq.com/press-release/quidel-receives-ce-mark-for-savannar-multiplex-molecular-analyzer-and-respiratory,"JUL 14, 2021 7:00AM EDT"
QGEN,https://www.nasdaq.com/press-release/qiagen-n.v.-conference-call-on-july-13-to-discuss-preliminary-q2-2021-results-2021-07,"JUL 12, 2021 8:00AM EDT"
QLGN,https://www.nasdaq.com/press-release/qualigen-therapeutics-inc.-announces-submission-of-investigational-new-drug-ind,"JUN 30, 2021 7:30AM EDT"
QLI,https://www.nasdaq.com/press-release/qilian-international-holding-group-limited-enters-into-investment-agreement-for-pig,"JUL 6, 2021 4:05PM EDT"
QTNT,https://www.nasdaq.com/press-release/quotient-limited-announces-departure-of-chief-financial-officer-peter-buhler-2021-07,"JUN 9, 2021 7:00AM EDT"
QURE,https://www.nasdaq.com/press-release/uniqure-announces-presentations-at-upcoming-international-society-on-thrombosis-and,"JUL 2, 2021 8:00AM EDT"
RAD,https://www.nasdaq.com/press-release/rite-aid-releases-third-annual-corporate-sustainability-report-2021-06-24,"JUN 28, 2021 5:10AM EDT"
RAPT,https://www.nasdaq.com/press-release/rapt-therapeutics-announces-closing-of-public-offering-of-common-stock-and-full,"MAY 25, 2021 7:00AM EDT"
RARE,https://www.nasdaq.com/press-release/media-advisory%3A-ultragenyx-announces-mepseviir-vestronidase-alfa-receives,"JUL 6, 2021 8:00AM EDT"
RCEL,https://www.nasdaq.com/press-release/avita-medical-announces-inclusion-in-the-russell-3000-index-2021-06-29,"JUL 14, 2021 8:05AM EDT"
RCKT,https://www.nasdaq.com/press-release/rocket-pharmaceuticals-presents-positive-clinical-data-from-fanconi-anemia-leukocyte,"JUN 30, 2021 8:55AM EDT"
RCUS,https://www.nasdaq.com/press-release/arcus-biosciences-announces-new-employment-inducement-grants-2021-07-12,"JUL 12, 2021 8:29AM EDT"
RDHL,https://www.nasdaq.com/press-release/redhill-biopharmas-movantikr-added-as-unrestricted-preferred-brand-to-a-major,"JUN 4, 2021 9:15AM EDT"
RDNT,https://www.nasdaq.com/press-release/radnet-inc.-and-jefferies-to-host-a-teach-in-on-artificial-intelligence-within,"JUN 28, 2021 7:00AM EDT"
RDUS,https://www.nasdaq.com/press-release/radius-health-business-update-2021-06-02,"JUL 8, 2021 11:20AM EDT"
RDY,https://www.nasdaq.com/press-release/dr.-reddys-laboratories-announces-filing-of-annual-report-on-form-20-f-2021-07-01,"JUL 7, 2021 8:00AM EDT"
REGN,https://www.nasdaq.com/press-release/regeneron-to-report-second-quarter-2021-financial-and-operating-results-and-host,"MAR 31, 2021 4:10PM EDT"
REPH,https://www.nasdaq.com/press-release/recro-enters-development-and-manufacturing-agreement-with-new-client-2021-07-13,"JUN 28, 2021 4:05PM EDT"
REPL,https://www.nasdaq.com/press-release/replimune-to-present-at-the-william-blair-biotech-focus-conference-2021-2021-07-07,"JUL 13, 2021 1:30AM EDT"
RETA,https://www.nasdaq.com/press-release/reata-pharmaceuticals-announces-participation-in-the-goldman-sachs-42nd-annual-global,"MAY 12, 2021 4:05PM EDT"
RGEN,https://www.nasdaq.com/press-release/repligen-to-report-second-quarter-2021-financial-results-2021-07-13,"JUN 14, 2021 7:45AM EDT"
RGLS,https://www.nasdaq.com/press-release/regulus-therapeutics-presents-additional-data-from-its-autosomal-dominant-polycystic,"JUL 7, 2021 4:05PM EDT"
RGNX,https://www.nasdaq.com/press-release/regenxbio-to-participate-in-upcoming-investor-conferences-2021-06-09,"JUN 4, 2021 9:00AM EDT"
RIGL,https://www.nasdaq.com/press-release/new-tavalisser-data-analyses-to-be-presented-at-international-society-on-thrombosis,"JUN 24, 2021 8:02AM EDT"
RLAY,,"JUL 7, 2021 4:01PM EDT"
RLMD,https://www.nasdaq.com/press-release/relmada-therapeutics-to-present-data-at-the-college-on-problems-of-drug-dependence,"JUL 1, 2021 4:45PM EDT"
RMD,https://www.nasdaq.com/press-release/resmed-announces-participation-in-the-goldman-sachs-42nd-annual-global-healthcare,"JUL 6, 2021 8:05AM EDT"
RMED,https://www.nasdaq.com/press-release/ra-medical-systems-announces-progress-with-guidewire-compatible-catheter-design-and,"JUL 6, 2021 4:30PM EDT"
RMTI,https://www.nasdaq.com/press-release/rockwell-medical-inc.-files-pre-ind-meeting-request-with-fda-for-its-proposed,"JUL 6, 2021 2:34PM EDT"
RNA,https://www.nasdaq.com/press-release/avidity-biosciences-announces-updates-on-the-pipeline-and-platform-at-virtual,"JUN 30, 2021 6:40PM EDT"
RNLX,,"JUL 7, 2021 7:00AM EDT"
RPRX,https://www.nasdaq.com/press-release/royalty-pharma-to-present-at-upcoming-investor-conferences-2021-06-07,"JUN 18, 2021 8:00AM EDT"
RPTX,https://www.nasdaq.com/press-release/repare-therapeutics-to-participate-at-the-42nd-annual-goldman-sachs-virtual-global,"MAY 6, 2021 4:05PM EDT"
RUBY,https://www.nasdaq.com/press-release/rubius-therapeutics-announces-first-patient-dosed-with-rtx-240-in-combination-with,"MAY 18, 2021 8:00AM EDT"
RVMD,https://www.nasdaq.com/press-release/revolution-medicines-announces-publication-of-scientific-paper-describing-novel-class,"MAY 14, 2021 9:18AM EDT"
RVNC,https://www.nasdaq.com/press-release/revance-to-participate-in-upcoming-virtual-healthcare-conferences-2021-05-26,"MAY 5, 2021 4:01PM EDT"
RVP,https://www.nasdaq.com/press-release/retractable-technologies-inc.-announces-buyback-plan-and-payment-of-all-dividends,"JUN 2, 2021 9:00AM EDT"
RVPH,https://www.nasdaq.com/press-release/reviva-added-to-russell-microcapr-index-2021-06-28,"JUL 14, 2021 8:15AM EDT"
RVPHW,,"MAY 18, 2021 7:30AM EDT"
RWLK,https://www.nasdaq.com/press-release/rewalk-robotics-reports-first-quarter-2021-financial-results-2021-05-11,"JUN 15, 2021 7:09AM EDT"
RYTM,https://www.nasdaq.com/press-release/rhythm-pharmaceuticals-to-present-at-jefferies-virtual-healthcare-conference-2021-05,"JUL 9, 2021 8:00AM EDT"
RZLT,https://www.nasdaq.com/press-release/rezolute-added-to-russell-microcapr-index-2021-06-28,"JUL 9, 2021 8:00AM EDT"
SAGE,https://www.nasdaq.com/press-release/sage-therapeutics-to-participate-in-cowens-psychedelics-novel-mechanisms-in,"JUN 22, 2021 4:01PM EDT"
SANA,https://www.nasdaq.com/press-release/sana-biotechnology-presents-data-at-isscr-2021-virtual-annual-meeting-showing,"MAY 10, 2021 9:00AM EDT"
SAVA,https://www.nasdaq.com/press-release/cassava-sciences-selects-clinical-research-organization-for-phase-3-clinical-program,"MAY 25, 2021 8:30AM EDT"
SBBP,https://www.nasdaq.com/press-release/strongbridge-biopharma-plc-announces-publication-of-long-term-efficacy-and-safety,"JUL 8, 2021 7:00AM EDT"
SBTX,https://www.nasdaq.com/press-release/silverback-therapeutics-announces-clinical-supply-agreement-with-regeneron-to,"JUN 30, 2021 10:47AM EDT"
SCPH,https://www.nasdaq.com/press-release/scpharmaceuticals-inc.-announces-positive-top-line-results-from-freedom-hf-study-2021,"JUN 28, 2021 8:30AM EDT"
SCPS,https://www.nasdaq.com/press-release/scopus-biopharma-announces-new-management-appointment-following-acquisition-of,"JUN 28, 2021 7:00AM EDT"
SCYX,https://www.nasdaq.com/press-release/scynexis-announces-three-oral-presentations-of-ibrexafungerp-demonstrating-clinical,"FEB 19, 2021 8:00AM EST"
SDC,https://www.nasdaq.com/press-release/smiledirectclub-partners-with-naacp-for-new-scholarship-2021-05-27,"JUN 17, 2021 7:30AM EDT"
SDGR,,"JUN 24, 2021 2:00PM EDT"
SEEL,https://www.nasdaq.com/press-release/seelos-therapeutics-to-participate-in-two-investor-conferences-in-august-2021-07-14,"JUN 29, 2021 7:00AM EDT"
SELB,https://www.nasdaq.com/press-release/selecta-biosciences-to-participate-at-the-william-blair-biotech-focus-conference-2021,"JUL 14, 2021 8:00AM EDT"
SEM,https://www.nasdaq.com/press-release/centers-for-disease-control-and-prevention-cdc-releases-study-on-physical-health-and,"JUN 9, 2021 8:01AM EDT"
SESN,https://www.nasdaq.com/press-release/sesen-bio-announces-productive-late-cycle-meeting-with-the-fda-for-vicineumtm-2021-07,"JUL 10, 2021 4:15AM EDT"
SGEN,https://www.nasdaq.com/press-release/u.s.-fda-grants-regular-approval-and-expands-indication-for-padcevr-enfortumab,"JUL 7, 2021 8:00AM EDT"
SGMO,https://www.nasdaq.com/press-release/sangamo-therapeutics-appoints-prathyusha-duraibabu-cpa-mba-to-chief-financial-officer,"JUN 18, 2021 10:00AM EDT"
SGRY,https://www.nasdaq.com/press-release/surgery-partners-inc.-announces-second-quarter-2021-earnings-release-date-and,"JUL 7, 2021 4:05PM EDT"
SGTX,https://www.nasdaq.com/press-release/sigilon-therapeutics-announces-clinical-hold-on-sig-001-phase-1-2-study-in-hemophilia,"JUL 7, 2021 4:30PM EDT"
SHC,https://www.nasdaq.com/press-release/sotera-health-announces-q2-2021-earnings-release-date-2021-07-12,"JUN 24, 2021 10:56PM EDT"
SIBN,https://www.nasdaq.com/press-release/si-bone-inc.-announces-centene-establishes-positive-coverage-for-mis-si-joint-fusion,"JUN 2, 2021 10:00AM EDT"
SIEN,https://www.nasdaq.com/press-release/sientra-announces-appointment-of-chief-financial-officer-2021-07-12,"JUN 29, 2021 7:30AM EDT"
SIGA,https://www.nasdaq.com/press-release/siga-supplies-tpoxxr-tecovirimat-as-compassionate-treatment-for-monkeypox-case-in-the,"JUN 30, 2021 8:05AM EDT"
SILK,https://www.nasdaq.com/press-release/first-ever-standard-surgical-risk-patient-tcar-data-to-be-presented-at-the-society,"MAY 26, 2021 6:45AM EDT"
SINT,,"JUL 14, 2021 8:00AM EDT"
SIOX,https://www.nasdaq.com/press-release/sio-gene-therapies-announces-fiscal-year-2020-year-end-financial-results-and-expected,"JUL 13, 2021 7:00AM EDT"
SLDB,https://www.nasdaq.com/press-release/solid-biosciences-reports-inducement-grant-to-new-senior-vice-president-clinical,"JUN 14, 2021 7:00AM EDT"
SLGL,https://www.nasdaq.com/press-release/sol-gel-announces-pipeline-update-and-future-development-plans-2021-06-28,"JUL 7, 2021 8:00AM EDT"
SLN,https://www.nasdaq.com/press-release/silence-therapeutics-receives-remaining-%2440-million-from-astrazeneca-as-part-of,"JUN 24, 2021 4:05PM EDT"
SLNO,https://www.nasdaq.com/press-release/soleno-therapeutics-provides-regulatory-update-on-dccr-for-the-treatment-of-prader-1,"JUL 1, 2021 12:14PM EDT"
SLRX,https://www.nasdaq.com/press-release/salarius-pharmaceuticals-announces-aundrietta-duncan-ph.d.-to-present-during-virtual,"JUL 13, 2021 8:00AM EDT"
SLS,https://www.nasdaq.com/press-release/sellas-reports-promising-updated-clinical-data-and-initial-immune-response-profiles,"JUL 9, 2021 6:30AM EDT"
SMMT,https://www.nasdaq.com/press-release/summit-therapeutics-presents-breakthrough-research-data-from-phase-ii-studies,"JUL 9, 2021 7:30AM EDT"
SMTI,https://www.nasdaq.com/press-release/sanara-medtech-inc.-announces-exclusive-partnership-with-pixalere-healthcare-inc.-to,"JUN 22, 2021 5:05PM EDT"
SNCA,,"JUN 30, 2021 7:30AM EDT"
SNDX,https://www.nasdaq.com/press-release/sndx-5613-granted-fda-fast-track-designation-for-the-treatment-of-relapsed-refractory,"JUL 5, 2021 6:16AM EDT"
SNGX,https://www.nasdaq.com/press-release/50-companies-to-present-at-the-access-to-giving-virtual-investor-conference-on-july-0,"JUN 30, 2021 11:00AM EDT"
SNGXW,,"MAY 26, 2021 7:32PM EDT"
SNN,https://www.nasdaq.com/press-release/smithnephew-launches-the-fast-fixtm-flex-meniscal-repair-system-extends-all-inside,"JUL 8, 2021 7:59AM EDT"
SNOA,https://www.nasdaq.com/press-release/sonoma-pharmaceuticals-and-emc-pharma-announce-an-exclusive-partnership-to-expand,"JUN 3, 2021 4:05PM EDT"
SNSE,https://www.nasdaq.com/press-release/sensei-biotherapeutics-announces-prioritization-of-next-generation-multi-antigenic,"JUL 12, 2021 7:30AM EDT"
SNSS,,"JUL 14, 2021 7:05AM EDT"
SNY,https://www.nasdaq.com/press-release/sanofi-announces-paris-2024-premium-partnership-for-the-olympic-and-paralympic-games,"JUL 12, 2021 4:05PM EDT"
SOLY,https://www.nasdaq.com/press-release/soliton-reports-first-quarter-2021-results-2021-05-12,"JUN 28, 2021 7:00AM EDT"
SONN,https://www.nasdaq.com/press-release/sonnet-biotherapeutics-announces-change-in-date-of-annual-meeting-2021-06-14,"JUN 29, 2021 9:00AM EDT"
SPNE,https://www.nasdaq.com/press-release/seaspine-announces-fda-510k-clearance-of-7d-surgical-percutaneous-spine-module-for,"MAY 25, 2021 8:48AM EDT"
SPPI,https://www.nasdaq.com/press-release/spectrum-pharmaceuticals-presents-poziotinib-data-in-patients-with-brain-metastases,"JUL 6, 2021 7:00AM EDT"
SPRB,https://www.nasdaq.com/press-release/spruce-biosciences-appoints-renowned-drug-developer-kirk-ways-m.d.-ph.d.-to-board-of,"JUL 7, 2021 2:54PM EDT"
SPRO,https://www.nasdaq.com/press-release/spero-therapeutics-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021-07,"JUN 9, 2021 7:30AM EDT"
SQZ,https://www.nasdaq.com/press-release/sqz-biotechnologies-strengthens-board-with-global-commercial-and-clinical-development,"JUL 12, 2021 7:00AM EDT"
SRDX,https://www.nasdaq.com/press-release/surmodics-builds-thrombectomy-portfolio-with-acquisition-of-vetex-medical-limited,"MAR 5, 2021 6:55AM EST"
SRGA,https://www.nasdaq.com/press-release/surgalign-holdings-inc.-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-1,"JUL 8, 2021 7:00AM EDT"
SRNE,https://www.nasdaq.com/press-release/fda-clears-sorrento-phase-2-trial-of-non-opioid-product-candidate-resiniferatoxin-rtx,"JUN 23, 2021 8:00AM EDT"
SRPT,https://www.nasdaq.com/press-release/sarepta-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-22,"JUN 21, 2021 8:00AM EDT"
SRRA,https://www.nasdaq.com/press-release/sierra-oncology-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07,"JUN 4, 2021 8:00AM EDT"
SRRK,https://www.nasdaq.com/press-release/scholar-rock-to-present-apitegromab-topaz-phase-2-trial-results-highlighting,"JUL 12, 2021 8:30AM EDT"
SRTS,https://www.nasdaq.com/press-release/sensus-healthcare-reports-first-quarter-2021-financial-results-2021-05-06,"JUN 30, 2021 8:00AM EDT"
SSKN,https://www.nasdaq.com/press-release/strata-skin-sciences-to-participate-in-the-oppenheimer-medtech-tools-diagnostics,"MAY 25, 2021 6:50AM EDT"
SSY,https://www.nasdaq.com/press-release/sunlink-health-systems-inc.-announces-fiscal-2021-third-quarter-results-and-covid-19,"JUN 10, 2021 4:17PM EDT"
STAA,https://www.nasdaq.com/press-release/staar-surgical-reports-record-first-quarter-2021-net-sales-of-%2450.8-million-up-44-y-y,"JUL 6, 2021 7:00AM EDT"
STE,https://www.nasdaq.com/press-release/steris-completes-the-acquisition-of-cantel-medical-2021-06-02,"JUN 15, 2021 9:21AM EDT"
STIM,https://www.nasdaq.com/press-release/neuronetics-launches-enhanced-digital-resource-center-for-neurostar-providers-2021-07,"JUL 6, 2021 4:15PM EDT"
STOK,https://www.nasdaq.com/press-release/stoke-therapeutics-to-present-at-the-ubs-global-healthcare-virtual-conference-2021-05,"JUL 8, 2021 9:00AM EDT"
STRO,https://www.nasdaq.com/press-release/sutro-biopharma-to-participate-in-two-virtual-investor-conferences-in-june-2021-06-15,"JUL 14, 2021 8:00AM EDT"
STRR,https://www.nasdaq.com/press-release/star-equity-holdings-inc.-to-present-at-the-access-to-giving-virtual-conference-on,"FEB 12, 2021 4:05PM EST"
STRRP,https://www.nasdaq.com/press-release/star-equity-holdings-inc.-to-present-at-the-access-to-giving-virtual-conference-on,"JUN 30, 2021 6:00AM EDT"
STSA,https://www.nasdaq.com/press-release/satsuma-pharmaceuticals-to-present-at-svb-leerinks-cns-forum-2021-06-22,"MAY 11, 2021 10:00AM EDT"
STTK,,"JUN 9, 2021 4:30PM EDT"
STXS,https://www.nasdaq.com/press-release/stereotaxis-reports-2021-first-quarter-financial-results-2021-05-10,"APR 15, 2021 6:03PM EDT"
SUPN,https://www.nasdaq.com/press-release/supernus-to-present-at-jefferies-virtual-healthcare-conference-2021-05-25,"JUL 7, 2021 8:00AM EDT"
SURF,https://www.nasdaq.com/press-release/surface-oncology-appoints-denice-torres-to-board-of-directors-2021-07-08,"JUL 8, 2021 7:00AM EDT"
SVRA,https://www.nasdaq.com/press-release/savara-announces-first-patient-dosed-in-pivotal-phase-3-autoimmune-pulmonary-alveolar,"JUL 7, 2021 8:30AM EDT"
SWAV,https://www.nasdaq.com/press-release/publications-validate-clinical-safety-and-efficacy-of-shockwave-intravascular,"JUN 30, 2021 8:00AM EDT"
SWTX,https://www.nasdaq.com/press-release/precision-biosciences-and-springworks-therapeutics-dose-first-patient-in-expanded,"JUL 12, 2021 8:30AM EDT"
SXTC,https://www.nasdaq.com/press-release/china-sxt-pharmaceuticals-inc.-announces-1-for-4-reverse-share-split-2021-02-19,"JUL 12, 2021 10:45AM EDT"
SYBX,https://www.nasdaq.com/press-release/synlogic-enters-research-collaboration-with-roche-for-development-of-novel-therapy-to,"JUN 28, 2021 8:30AM EDT"
SYK,https://www.nasdaq.com/press-release/stryker-to-host-conference-call-on-july-27-2021-2021-06-24,"MAR 15, 2021 8:50AM EDT"
SYN,https://www.nasdaq.com/press-release/synthetic-biologics-provides-update-on-syn-020-intestinal-alkaline-phosphatase-phase,"JUN 28, 2021 8:00AM EDT"
SYNH,https://www.nasdaq.com/press-release/syneos-health-names-michael-brooks-chief-development-officer-2021-07-14,"JUN 25, 2021 8:50AM EDT"
SYRS,https://www.nasdaq.com/press-release/syros-pharmaceuticals-to-present-at-jmp-securities-2021-life-sciences-conference-2021,"JUN 9, 2021 7:05AM EDT"
TAK,https://www.nasdaq.com/press-release/new-data-from-the-phase-3-help-studytm-open-label-extension-evaluating-safety-and,"JUL 7, 2021 8:28AM EDT"
TARA,https://www.nasdaq.com/press-release/protara-therapeutics-to-present-at-the-ladenburg-thalmann-healthcare-conference-2021,"JUL 14, 2021 9:00AM EDT"
TARO,https://www.nasdaq.com/press-release/taro-annual-report-on-form-20-f-available-for-fiscal-year-ended-march-31-2021-2021-06,"JUN 24, 2021 7:05AM EDT"
TARS,https://www.nasdaq.com/press-release/tarsus-pharmaceuticals-inc.-to-participate-in-the-ladenburg-thalmann-2021-virtual,"JUN 10, 2021 4:30PM EDT"
TBIO,https://www.nasdaq.com/press-release/translate-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2021-07-07,"MAY 12, 2021 4:30PM EDT"
TBPH,https://www.nasdaq.com/press-release/theravance-biopharma-inc.-announces-pricing-of-public-offering-of-ordinary-shares,"JUN 22, 2021 4:45PM EDT"
TCDA,https://www.nasdaq.com/press-release/tricida-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference-2021,"JUL 9, 2021 7:00AM EDT"
TCMD,https://www.nasdaq.com/press-release/tactile-medical-to-release-second-quarter-of-fiscal-year-2021-financial-results-on,"JUL 7, 2021 6:30AM EDT"
TCON,https://www.nasdaq.com/press-release/tracon-pharmaceuticals-announces-appointment-of-ya-huang-as-executive-director-of,"JUL 9, 2021 7:30AM EDT"
TCRR,https://www.nasdaq.com/press-release/tcr2-therapeutics-to-participate-in-two-upcoming-conferences-in-june-2021-05-26,"JUL 14, 2021 8:00AM EDT"
TDOC,https://www.nasdaq.com/press-release/teladoc-health-and-microsoft-collaborate-to-create-a-unified-practice-experience-for,"JUN 10, 2021 2:00AM EDT"
TECH,https://www.nasdaq.com/press-release/bio-techne-to-host-conference-call-on-august-5-2021-to-announce-fourth-quarter-2021,"JUN 28, 2021 9:26AM EDT"
TELA,https://www.nasdaq.com/press-release/tela-bio-to-participate-in-upcoming-jmp-securities-life-sciences-conference-2021-06,"JUL 6, 2021 7:00AM EDT"
TENX,https://www.nasdaq.com/press-release/tenax-therapeutics-announces-ceo-transition-and-%2410-million-pipe-offering-priced-at,"JUL 9, 2021 8:30AM EDT"
TERN,https://www.nasdaq.com/press-release/terns-announces-initiation-of-patient-dosing-in-aviation-phase-1b-nash-clinical-trial,"JUL 8, 2021 1:59PM EDT"
TEVA,https://www.nasdaq.com/press-release/teva-to-host-conference-call-to-discuss-second-quarter-2021-financial-results-at-8-a,"JUN 29, 2021 7:30AM EDT"
TFFP,https://www.nasdaq.com/press-release/tff-pharmaceuticals-announces-completion-of-enrollment-and-preliminary-data-from-its,"JUL 13, 2021 8:00AM EDT"
TFX,https://www.nasdaq.com/press-release/largest-u.s.-healthcare-claims-and-utilization-analysis-for-bph-procedures-reveals,"JUL 7, 2021 8:00AM EDT"
TGTX,https://www.nasdaq.com/press-release/tg-therapeutics-to-participate-in-the-ladenburg-thalmann-2021-healthcare-conference,"MAY 19, 2021 4:01PM EDT"
THC,https://www.nasdaq.com/press-release/tenet-to-report-its-second-quarter-2021-results-on-july-21-2021-06-22,"JUN 29, 2021 8:00AM EDT"
THTX,https://www.nasdaq.com/press-release/theratechnologies-to-announce-financial-results-for-its-second-quarter-fiscal-2021,"JUL 8, 2021 8:30AM EDT"
TLC,https://www.nasdaq.com/press-release/tlc-announces-details-of-stock-swap-transactions-2021-07-05,"JUL 8, 2021 11:20AM EDT"
TLGT,https://www.nasdaq.com/press-release/teligent-inc.-announces-adjournment-of-annual-meeting-of-stockholders-2021-06-30,"JUN 2, 2021 4:52PM EDT"
TLMD,https://www.nasdaq.com/press-release/soc-telemed-announces-pricing-of-public-offering-of-class-a-common-stock-2021-05-26,"JUL 8, 2021 4:14PM EDT"
TLMDW,,"MAY 12, 2021 7:00AM EDT"
TLSA,https://www.nasdaq.com/press-release/tiziana-life-sciences-plc-ads-ex-dividend-date-scheduled-for-july-09-2021-2021-07-08,"JUL 6, 2021 4:30PM EDT"
TMBR,https://www.nasdaq.com/press-release/timber-pharmaceuticals-announces-adjournment-of-annual-meeting-2021-06-03,"JUL 8, 2021 7:00AM EDT"
TMDI,https://www.nasdaq.com/press-release/titan-medical-announces-appointment-of-new-chief-financial-officer-2021-07-12,"JUL 13, 2021 8:45AM EDT"
TMDX,https://www.nasdaq.com/press-release/transmedics-stock-trading-halted-today-fda-advisory-committee-to-review-premarket-0,"MAY 20, 2021 7:46AM EDT"
TNDM,https://www.nasdaq.com/press-release/tandem-diabetes-care-to-announce-second-quarter-2021-financial-results-on-august-4,"JUL 7, 2021 8:04AM EDT"
TNXP,https://www.nasdaq.com/press-release/tonix-pharmaceuticals-added-to-russell-2000r-and-russell-3000r-indexes-2021-06-28,"JUL 1, 2021 4:01PM EDT"
TPTX,https://www.nasdaq.com/press-release/turning-point-therapeutics-appoints-paolo-tombesi-as-executive-vice-president-and,"JUL 13, 2021 4:05PM EDT"
TRIB,https://www.nasdaq.com/press-release/trinity-biotech-announces-results-for-q1-2021-2021-05-25,"JUN 11, 2021 3:00AM EDT"
TRIL,https://www.nasdaq.com/press-release/trillium-therapeutics-announces-dosing-of-first-patient-in-phase-1b-2-study-of-tti-0,"MAY 27, 2021 4:01PM EDT"
TRUP,https://www.nasdaq.com/press-release/trupanion-partnership-with-we-rate-dogs-shines-light-on-mental-health-challenges,"JUN 21, 2021 7:30AM EDT"
TRVI,https://www.nasdaq.com/press-release/trevi-therapeutics-to-present-at-2021-bio-digital-conference-2021-06-09,"JUL 6, 2021 7:30AM EDT"
TRVN,https://www.nasdaq.com/press-release/trevena-announces-publication-of-olinvykr-health-economic-model-in-journal-of,"MAY 13, 2021 8:00AM EDT"
TRXC,https://www.nasdaq.com/press-release/asensus-surgical-announces-finalization-of-name-and-ticker-symbol-change-2021-03-05,"MAY 19, 2021 2:17AM EDT"
TSHA,https://www.nasdaq.com/press-release/taysha-gene-therapies-to-participate-in-upcoming-july-investor-healthcare-conference,"JUL 6, 2021 8:37AM EDT"
TTNP,https://www.nasdaq.com/press-release/titan-announces-positive-results-from-the-first-studies-of-tp-2021-implant-in-an,"JUN 14, 2021 7:00AM EDT"
TTOO,https://www.nasdaq.com/press-release/t2-biosystems-to-participate-at-clinical-conferences-in-june-and-july-2021-2021-06-21,"JUL 6, 2021 7:00AM EDT"
TVTX,https://www.nasdaq.com/press-release/travere-therapeutics-announces-presentation-of-abstracts-at-era-edta-congress-2021,"JUL 13, 2021 4:05PM EDT"
TVTY,https://www.nasdaq.com/press-release/silversneakers-opens-nominations-for-2021-member-of-the-year-awards-2021-07-12,"JUN 21, 2021 8:00AM EDT"
TWST,https://www.nasdaq.com/press-release/twist-bioscience-acquires-ngs-library-preparation-maker-igenomx-2021-06-30,"MAY 24, 2021 4:05PM EDT"
TXMD,https://www.nasdaq.com/press-release/therapeuticsmd-announces-submission-of-low-dose-bijuvar-0.5-mg-100-mg-supplemental,"JUN 16, 2021 7:30AM EDT"
TYME,https://www.nasdaq.com/press-release/tyme-technologies-inc.-completes-strategic-review-announces-oasis-breast-trial-with,"JUL 1, 2021 4:01PM EDT"
UBX,https://www.nasdaq.com/press-release/unity-biotechnology-announces-positive-data-from-phase-1-clinical-trial-of-ubx1325-in,"JUL 6, 2021 6:05AM EDT"
UFPT,https://www.nasdaq.com/press-release/ufp-technologies-to-present-virtually-and-host-1x1-investor-meetings-at-the-11th,"MAY 26, 2021 4:05PM EDT"
UHS,https://www.nasdaq.com/press-release/universal-health-services-inc.-announces-date-for-second-quarter-2021-earnings,"JUL 2, 2021 8:30AM EDT"
UNH,https://www.nasdaq.com/press-release/unitedhealthcare-introduces-the-use-of-predictive-analytics-to-expand-its,"JUL 8, 2021 8:30AM EDT"
URGN,https://www.nasdaq.com/press-release/urogen-pharma-reports-strong-preliminary-jelmytor-sales-for-second-quarter-2021-2021,"JUL 7, 2021 7:30AM EDT"
UROV,https://www.nasdaq.com/press-release/urovant-sciences-provides-merger-update-and-reports-third-quarter-fiscal-year-2020,"JUL 13, 2021 9:15AM EDT"
